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\H I S T O R I C A L
INTRODUCTION
Tuberculosis has plagued mankind for many
thousands of years. Human skeletons have been unearthed
which show evidence of tuberculous lesions and establish
1
that the disease was known as early as 5000 B.C. 
Hippocrates, ” the father of medicine” , described 
its semiology and pathology more than 2000 years ago,, 
mentioning phymata or nodules in the lungs, and stressed 
the importance of personal hygiene with proper diet 
in the control of the disease. Tuberculosis became 
commonly known as consumption or phthisis because of 
its most conspicuous external feature, wasting, and in 
the past was considered to be of many varieties and 
origins. The unity of the disease, however, was 
established experimentally by Robert Koch when he 
identified the causative organism in 1882 and knowledge 
of the disease has progressed rapidly from that time.
Even today, despite the magnitude of achievements in the 
field of chemotherapy, tuberculosis still remains a 
serious threat to life in many parts of the world.
In recent years, however, mortality from tuberculosis
2 3 4
has declined rapidly and recent statistical surveys 9 
have shown this to have been particularly marked since 
1947. Statistics for the period 1947 to 1953 show
that the fall in death rate in western countries due to
2respiratory tuberculosis has ranged from 53 per cent in
5
France to 83 per cent in Ireland. Chronologically this 
corresponds more or less with the introduction of 
streptomycin, pramino-salicylic acid and isoniazid (isonicotinic 
acid hydrazide). The decline in mortality from 
tuberculosis, however, has not been accompanied by a
5,6
parallel decrease in the morbidity. This may be 
attributed to better methods of investigation and, in 
particular, to mass-radiography which has revealed many 
new cases which otherwise would have remained undetected 
until some later date.
The Nature of the. Disease.
Tuberculosis is characterised pathologically by 
inflammatory infiltrations, tubercles, caseous necrosis, 
abcesses, fibrosis and calcification. This communicable 
disease mostly affects the lungs due to inhalation of 
tubercle bacilli, though the gastro-intestinal and 
genito-urinary tracts, bones and joints may occasionally 
be infested.
The causatine organism, the tubercle bacillus, was 
first described by Robert Koch in 18821, and various types,
7
human, bovine and avian are known. Infection in man is 
mainly by human or bovine types but seldom by avian strain.
The tubercle bacillus belongs to the genus ' ’Mycobacteria,f
3which is characterised by its acid fastness, a property
8
attributed mainly to mycolic acid which is present in
combination with polysaccharides. This characteristic is
most pronounced in the lipoids of the cytoplasmic membrane
9
and in the internal granules of the cell.
10
The concept of a protective lipoid capsule which
possibly arose from the hydrophobic and lipophilic properties
n
of the tubercle bacillus has been proved to be erroneous.
The minute architecture of tubercle bacillus has been revealed
12
by electron microscopy, and the central cytoplasmic mass 
shown to be surrounded by thin cytoplasmic membranes enclosed 
by a thin cell wall. Both extracellular and intracellular 
constituents have been investigated extensively in the past 
because of the unique immunological and bacteriological 
properties of Mycobacterium tuberculosis. Possibly no other 
bacterial group has received quite the same attention as the 
Mycobacteria or yielded in return so rich a harvest of 
chemical knowledge.
CHEMISTRY OF MYCOBACTERIUM TUBERCULOSIS
Like all other microbial cells, the tubercle bacillus
synthesises a wide variety of giant molecules or macromolecules
from the simplest of carbon and nitrogen sources, such as
asparagine, glycerol, and salts of sodium, potassium 
13a
and magnesium • The number and complexity of
414
its macromolecular constituents is bewildering,
though their nature (polysaccharide, fat, protein and nucleic
acid) and proportion are dependent upon the type of 
15 is
medium and the strain of the organism. Macromolecules
obtained from tubercle bacillus have important biological
functions in the animal body. The proteins and
polysaccharides manifest specific biological activities
such as the M Tuberculin" reaction, whilst the lipoid
17
complexes cause tubercle and giant cell formation.
Today, isolation and study of constituents of the 
tubercle bacillus have not succeeded in opening any new 
approach to chemotherapeutic investigation. Such information, 
however, is essential to provide insight into the 
mechanism of the cell reactions. Some of the biologically 
important constituents which have been isolated from the 
tubercle bacillus are, therefore, briefly considered.here.
CARBOHYDRATES 
The complexity of the polysaccharides in tubercle 
bacillus is beyond doubt since more than eight 
structurally different polysaccharides have been isolated.
Some of these have been found to be present in combination 
with lipoids while others form complexes with nucleic acids 
or with proteins. These complex polysaccharides are
distributed throughout the cellular material and some
5diffuse from the outer surface into the culture medium. 
Accordingly, tubercle polysaccharides have been considered 
in three groups:
(a) those of somatic origin,
(b) those combined with the lipoids, and
(c ) those associated with the M tuberculin ” 
from the culture medium.
(a ) Polysaccharides Associated with Somatic Components of 
Defatted Cells.
Earlier investigations have been reviewed by
18 19
Stacey and Kent and Andre jew. In the past attempts
have been made to establish the presence of cellulose,
hemicellulose and chitin but these have not been confirmed
by more recent studies. The presence of glucosamine,
the essential component of chitin, however, has been
demonstrated in the carbohydrate fractions of the tubercle 
20
bacillus. Besides this, many investigators have
established the presence of glycogen by its reaction with
iodine and by enzymatic hydrolysis.
21
In 1925, Laidlaw and Dudley pioneered the study 
of carbohydrates in the bacillus by isolating a substance 
from defatted dead bacilli having the characteristics of 
glycogen. They also characterised another polysaccharide
620having [a] + 67° which on hydrolysis with dilute acid
yielded a mixture of reducing sugars containing 30 per cent
pentoses. The polysaccharide was found to be
serologically active in animals which had been immunised
with dead tubercle bacilli and this substance was
22
regarded as a hapten, Maxim isolated two polysaccharides 
having + 64.5° and + 80,2° respectively by
extracting fat-free bacilli with dilute acid, and showed
2 3 24
them to be serologically active, Heidelberger and Menzel 
extracted defatted cells by percolation with dilute acetic 
acid and also obtained two dextrorotary specific 
polysaccharides. The one with high rotation([a]p + 85°) 
yielded arabinose and D-mannose on hydrolysis, while
the other ([a]D + 34.7°) gave only D-arabinose. They also 
isolated identical polysaccharides from Mvcohantftrl um 
tuberculosis (bovine strain). Heidelberger and Menzel 
established that serological activity was related to the 
pentose fragments of the substances, and suggested that 
sugar acids were not responsible for immunological specificity 
in the tubercle bacillus. They also suggested that the 
constituents isolated from culture filtrates by Masucci, 
McAlpine and Glenn25 were identical with those in 
polysaccharides of somatic origin.
726
Gough isolated a serologically active
polysaccharide by the action of 4 per cent sodium hydroxide
2?
on the moist bacilli. Ludewig and Anderson, and
28
du Mont and Anderson also isolated from Mycobacterium 
tuberculosis (human strain) a purified polysaccharide fraction 
which yielded inositol, D-arabinose and D-mannose on 
hydrolysis. The latter authors also obtained the same 
results from avian strains of bacilli.
29
Chargaff and Schaefer using methods similar to
23
those of Heidelberger and Menzel isolated polysaccharide 
constituents from Bacillus Calmette Guerin (B.C.G. ). .
Besides glycogen, two specific polysaccharides were 
fractionated, and one having [a]p + 77c, yielded D-mannose, 
D-arabinose and small quantities of inositol and
30
D-glucosamine on hydrolysis. Karjala and Heidelberger 
isolated polysaccharides from an avian strain of tubercle 
bacilli with 3.5 per cent acetic acid. The active 
polysaccharide containing the greatest amount of pentoses 
showed the same immunological properties as those derived
31
from human and bovine strains. Chargaff and Moore 
demonstrated that purified glycogen fractions were inactive 
biologically.
It is evident that the various investigators have 
between them isolated a large number of polysaccharides by
. 8
adopting different procedures, but without embarking upon 
structural studies. Haworth, Kent and Stacey, however, 
have not only confirmed the existence of two stable
18
serologically active polysaccharides, one having [a]^ + 85°
from the somatic part of the cell and the other having 
18
[a]^ + 25° bound to the cellular lipoids, but also have
studied the details of their structure.
The polysaccharide of high dextrorotation was
32
isolated by defatting moist steam-killed cells with 
organic solvents and treating with N sodium hydroxide for a 
few days. The crude polysaccharide was precipitated by 
the addition of ethanol. After acidification, it was 
dialysed and again fractionated with ethanol. Methylation 
of the polysaccharide with dimethyl sulphate and sodium 
hydroxide yielded a brown gum which on hydrolysis with 
methanolic hydrogen chloride gave a mixture of methyl 
glycosides. These were fractionated using high vacuum 
and were characterised as 3,5-dimethyl-methyl-D-arabofuranoside,
2,3,4-trimethyl-methyl-L-rhamnopyranoside, 3,4,3-trimethyl- 
-methyl-D-mannopyranoside, 3,4-dimethy1-methyl-D-mannopyranoside 
and an unidentified dimethyl-methyl-2-acetamidohexoside in 
the molecular proportion of 5,5,5,4,1 respectively.
On the basis of these conclusions, the structure (1) has been
32
assigned to the somatic polysaccharide (the numerals 
represent points of mutual attachment).
Ri
R* * A1 2 M1*
2 
Ai
6
-2 K- M' N -----
R = L-rhamnopyranose, 
A = D-arbofuranose,
M = D-mannopyranose 
N * g-amino-hexose
(I )
In this representation, all the linkages engaging
the glycosidic groups have been depicted in the a-form.
The somatic polysaccharide molecule may be any multiple of
the above suggested structure linked glycosidically through
its amino sugar residue. Osmotic pressure determinations
indicated a minimum molecular weight of 12000, which suggests
that at lease three such structures are joined together in
the intact polysaccharide molecule.
(b) Polysaccharides combined with the Lipoids.
18
Certain earlier workers in this field observed the 
unusual complexity of the lipoid constituents of Mycobacterium
10
tuberculosis and attributed the property of acid fastness 
to the M fatM or lipoids present in the organisms.
3 3
Long and Campbell obtained a waxy substance which was 
found to be a difficultly hydrolysable ester of a high
34
molecular weight alcohol. Anderson and his collaborators 
undertook a systematic study of the lipoids of the tubercle 
bacilli, as a result of which carbohydrates have been 
shown to be associated by direct chemical combination with 
four types of lipoid substances:
(a) Acetone-soluble fats,
(b) Phosphatides,
(c ) Waxes and
(d ) Firmly bound lipoids.
The acetone-soluble fats were largely composed 
of free fatty acids in addition to fatty esters but were
35
devoid of glycerides. Alkaline hydrolysis of fats 
derived from human strain, but not those obtained from 
the bovine and avian strains of tubercle bacilli, yielded
36
a water-soluble disaccharide which was identified as trehalose.
37
The phosphatides or nitrogen- and phosphorus- containing 
fractions, when hydrolysed with 5 per cent sulphuric acid 
gave a mixture of fats (65 per cent) and water-soluble 
components (33.6 per cent) consisting of glycerophosphoric
11
acid, inositol, D-mannose and an unidentified hexose.
38
A chloroform-soluble wax yielded D-mannose, D-galactose and 
D-arabinose, together with small amounts of D-glucosamine
39
and inositol. Similar products were obtained from bovine
40
and.avian strains.
41
Saponification of firmly-bound lipoids afforded poly­
saccharides, having properties similar to those obtained 
from purified wax and were shown to contain D-arabinose,
43
D-mannose and D-galactose. Haworth, Kent and Stacey 
isolated a serologically active lipoid-bound polysaccharide 
by saponification of a urea extracted complex of heat-killed 
bacilli. This had [a]^8 + 25° in water. Structural 
studies of the polysaccharide were undertaken after purifica­
tion by fractionation and repeated methylation which afforded 
a brown' gum. Hydrolysis of the fully methylated poly­
saccharide with methanolic hydrochloric acid yielded 2,3,5- 
-trimethyl methyl-D-arabofuranoside, 3,5-dimethyl methyl-D- 
arabofuranoside, 2,3,6-trimethyl methyl-D-galactopyranoside,
3,4-dimethyl methyl-D-mannopyranoside and a dimethyl methyl- 
-D-glucosaminide in the molecular proportions of 2:5:5:2:1 
respectively. Structure (II) has been proposed for the 
lipoid-bound polysaccharide (the numerals represent points of 
mutual attachment).
A = D-arabofuranose M = D-mannopyranose,
G = D-galactopyranose N = D-glucosamine
( II )
(c) Polysaccharides Associated with Tuberculin and, the 
Culture Medium.
Culture filtrates obtained from the media after the 
growth of tubercle bacilli contain complex polysaccharides as
4 3
do the bacillary bodies themselves. Mueller isolated 
a polysaccharide from the six week old culture filtrate of 
tubercle bacilli in the form of a yellow gum free from 
proteins and having [a]D + 24.2°. This product though 
containing less than one per cent of nitrogen, reacted with 
immune serum at a dilution of one in a million. ' After acid 
hydrolysis, the product contained 54,8 per cent of pentoses 
and the specific rotation had changed to -22.9°. It was
13
suggested that the polysaccharide was similar in nature
21
to that isolated by Laidlaw and Dudley from the somatic
44
portion of the cell. Enders studies its biological 
properties and concluded that the polysaccharide induced 
lethal anaphylactic shock in tuberculous guinea pigs.
25 45
Masucci, McAlpine and Glenn, and Renfrew isolated a 
serologically active polysaccharide which on acid 
hydrolysis, liberated mannose, D-arabinose and an
46
unidentified sugar acid. McAlpine and Masucci isolated
two fractions, one of low and the other of high 
dextrorotation by fractional hydrolysis and attributed 
their biological activity to pentose constituents.
47
Dorset and Henley obtained a polysaccharide using 
Long's synthetic medium which yielded D-arabinose and 
D-mannose on hydrolysis. They claimed that the biological 
activity of this product was due to proteins (tuberculin) 
with which it was associated and these results were
48
subsequently confirmed by Seibert and Munday. Spiegel-
49
Adolf and Seibert investigated various tuberculins 
spectrographically and found that the tuberculin protein 
purified by trichloracetic acid (Purified protein derivatives; 
P.P.D. ) exhibited an absorption band at 265-267 mji which was 
identical with that displayed by deoxyribonucleic acid.
14
50
Seibert and her associates separated nucleic acid, 
polysaccharide and protein fractions of tuberculin by 
electrophoresis, a technique which was developed later
51
by Seibert and Watson for large scale work in this field. 
The relative immobility of the polysaccharide permitted its 
separation from the protein and nucleic acid, which move
52
independently at high pH. The nucleic acid did not
53 54
show any antigenic properties. 7
A distinction has now been made between the 
polysaccharides of the culture filtrate on the basis of 
electrophoretic analysis and ethyl alcohol fractionation.
The first of these, designated as " Polysaccharide 1 M
51
was separated by Seibert and Watson. It was shown to 
contain units of mannose, galactose and arabinose and was 
found to be highly active serologically. It did not elicit 
antibodies and had a relatively low molecular weight of 
about 7000-9000. The 11 Polysaccharide IIn was isolated
5 5
and examined by Seibert, Stacey and Kent and shown to be 
similar in structure to dextran. It gave a high precipitin 
titre with horse antituberculous serum and lower titre with 
anti-B.C.G. serum and with rabbit and human antituberculous 
sera. It was able to induce formation of homologous 
antibodies when injected into rabbits but did not product
15
56
any immunity. Kent has claimed that it contains about 
8 per cent of bound lipoid component and that the glucose 
units are joined by (1— >2) linkages.
A third polysaccharide isolated by Seibert from the 
supernatent remaining after precipitation of P.P.D. with 
half saturated ammonium sulphate, was purified by ultra-
57afiltration. More recently it has been shown by Stacey 
to contain 80 per cent of arabinose with small amounts of 
mannose and galactose and a trace of an amino sugar.
It is clear, therefore, that components of • 
polysaccharides in the culture filtrates resemble closely
5 7 0,
those present in the cells. Stacey has drawn attention 
to similarities in the structure of the somatic 
polysaccharides and more especially of the " lipoid bound" 
polysaccharide, to that of streptomycin; the streptose 
fragment of the latter corresponding to D-arabofuranose, 
the Ir-gluc os amine of streptomycin to D-hexosamine and the 
inositol (streptidine) of streptomycin to the hexoses.
There are grounds, therefore, for considering the 
possibility that streptomycin might act as a competitive 
metabolite by inhibiting the biosynthesis of an essential 
tuberculosis polysaccharide.
16
Biological Pj.oper.tie-S of Polysaccharides.
Various polysaccharide fractions isolated from the 
bacillus and culture filtrates react strongly in 
precipitin test with the serum of animals immunized against
21 42 50
tubercle bacilli ’ but none stimulate antibody
formation. These carbohydrates are, therefore, not true
46
antigens but rather haptens. Furthermore, they are 
non-toxic for the normal body and do not induce
17
hypersensitivity of the tissues.
LIPOIDS
The pioneering investigations of Anderson and his 
collaborators into the extraction and fractionation of 
lipoid components of Mycobacterium tuberculosis and other 
acid-fast bacilli with organic solvents have been extensively
349 589 59
reviewed elsewhere . Four main groups of lipoids
have been recognised on the basis of solubility relations,
viz: acetone-soluble fats, acetone-insoluble phosphatides,
chloroform-soluble waxes and the firmly-bound lipoids. A
general scheme for the fractionation of lipoids from tubercle
6 0 13^
bacilli has been cited by Seibert and Long . Biological 
studies of various fractions isolated by Anderson have been
61963
recorded by Sabin , and lipoids seem to play an important 
role in the process of tuberculous infections.
17
Lipoids constitute about 20 to 40 per cent of the 
tubercle bacillus, depending upon the composition of the
15 16
medium and the strain of the organism used • Acetone- 
-soluble fats and phosphatides have yielded on saponification 
mostly the normal fatty acids such as palmitic, stearic, n- 
hexacosanoic (C26H520a) and oleic acids besides several 
specific branched-chain fatty acids, of which the most 
important are the methyl-branched fatty acids,tuberculostearic 
acid and phthioic acids. On the other hand the chloroform- 
soluble waxes and firmly-bound lipoids gave mycoceranic acid, 
mycolic acid and a toxic fraction, 'cord factor?
Tuberculostearic acid (Ci9H3Q02) which was isolated by
64 62 65
Anderson and Chargaff , is biologically and optically 
inactive. Its structure assigned as (+)-10-methylstearic acid
, . 65
(III) by Spielman , is supported by the X-ray diffraction
CH3. (CH3 )7.CH. (CH2 )q .C00H 
I
CH3
(III)
. 6 6  67 
studies of Velick . Prout, Cason and Ingersoll have since
established its structure as the optically active (-)-10-
-methyloctadecanoic acid ([a]p ca.. -0.05°) by step-wise
synthesis. A new and improved method of synthesis of (+)-lo­
se
-methyloctadecanoic acid has been reported by Schmidt and Shirley •
18
6 9
Spielman and Anderson isolated phthioic acid, C26H520a,
as a white solid,m.p. 20-21°, [a]p + 12.6°, from the tubercle
bacillus, and considered it to be a saturated branched-chain
acid. Its name is derived from the fact that it causes
typical tubercular lesions on intraperitoneal injection into
test animals . Preliminary investigation led to the
erroneous assumption that crude phthioic acid was saturated.
This arose through a misinterpretation of the zero iodine
value of phthioic acid and the use of hydrogenation in its
70
isolation. Chanley and Polgar , however, drew attention 
to the non-reactivity of a,(3-unsaturated acids to halogens 
and showed that these dextrorotatory phthioic acids were in 
fact a,(3-unsaturated. Efficient fractionation by various
71~7 6
workers , has shown that phthioic acid is a complex mixture
of fatty acids containing at least thirteen saturated and
unsaturated acids.
a(3-Unsaturated acids consisting of at least six dextro-
rotatory a-alkyl-a(3-unsaturated acids have been identified
as C25-, C26-, C27- and C20- phthienoic acids. The latter
acid has been shown on the basis of physical data and the
Kuhn-Roth determination of C-methyl, to possess one more
branch in the chain than do the other phthienoic acids. The
7 7structure, 3,13,19-trimethyltricosanoic acid, proposed for
_ 78
c2 7 ~Phthienoic acid, was shown to be untenable • Cason and 
7 99 80
his associates, assigned it the partial structure,
19
L(+)-2,4-dimethy1-2-alkenoic acid and degradative studies
of mycolipenic acid, a dextrorotatory a,(3-unsaturated acid,
81
believed to be identical with C27-phthienoic acid, have 
shown this to be (+)-2,4,6-trimethyl tetracos-2-enoic acid
7 0 5 72 *
(IV). The physical constants cited by Polgar and by
74
Cason for the two acids are, however different.
CH3.(CH2 ) 17.CHMe.CH2.CHMe.CH:CMe.C 0 2H .
(IV)
Of the several laevorotatory saturated acids present 
in the lipoids of tubercle bacillus, mycocerosic acid, a 
C3i-laevorotatory saturated acid, discovered by Ginger and
82 73
Anderson has been assigned the structure (V) by Polgar , 
who has named it ,fmycoceranic acid”. More recently Cason
75
and Fonken have proposed the name ,tC3i-mycosanoic,t acid
CH3. (CH2 )n . CHMe. CH2. CHMe. CH2. CHMe. C02H .
(n is probably 21)
(V)
(C3iH6202 ) for an identical acid.
Mycolic acid, a long chain branched, saturated, fatty
83
acid, C33HX73O4, isolated by Stodola, Lesuk and Anderson 
from a human strain of tubercle bacillus, is at least partly
8
responsible for the property of acid fastness in Mycobacteria . 
It has been shown to contain carboxyl, hydroxyl and methoxyl
84
groups in the ratio Is 1:1. Degradation by pyrolysis at 
300° in vacuo, and chromic acid oxidation yielded n-hexacosanoic
20
acid (C2 6H5 2 O2 ), stearic acid and hexadecane-l,16-dicarboxylic 
acid. Chromatography of mycolic acid on alumina hy
85
Asselineau and Lederer gave two isomers, a- and |3- 
mycolic acids. Analytical data confirmed Andersonfs molecul­
ar formula for mycolic acid as CQ8Hi7 5 0 4 but still with an 
uncertainty of about +. 5CH2. Pyrolytic decomposition of 
the a- and (3- mycolic acids is characteristic of a-
substituted (3- hydroxy acids and the following mechanism
86
has been proposed , though the reaction seems to be more
R - CHOH - CH - C 0 0 H  > R - CHO + CHoCOOH
I I
C 2 4 H 4 9  C 2 4 H 4 9
(VI)
complicated than this would indicate since no aldehyde
was isolated. However the partial structure (VI) has been
confirmed by dehydration to the corresponding anhydro-
mycolic acid and subsequent ozonolysis. About forty
different types of mycolic acid having identical molecular
5 7 b
weights have been isolated from various strains of
Mycobacteria and tentative structures for some have been
proposed as follows 
/ 87a(i) a-mycolic acid (VII), 3-hydroxy-x-methoxy-mycolanoic
acid (CggHi7504),
21
0CH3 OH
I I
CH3 - (CH2 )2 4 - C - (CH2 )1 7 - CH - CH - COOH
(CHa )la (CH2 )3 3
I I
ch3 ch3
(VII)
87b
(ii) a2-mycolic acid (VIII), 3,7(?)-dihydroxy-
mycolanoic acid, (C8 8Hi7 4 0 4 +5CH3 ),
OH OH
CH3 -(CH2 )2 3 - CH2 - CH - CH - CH2 - CH - CH - CH - COOH
ii r2 (ch2 )2 3
CH3
Hi + R2 C3 iH8 2 +6 CH2
(VIII)
88
(iii) a-mycolic acid Brevannes (IX), 3,5(? )-dihydrosy-
mycolanoic acid (1-Brevannes).
Ri - CHOH - CH - CHOH - CH - COOH 
I 1
R2 C2 4H4 9
Ri + &2 = C58Hii8 ±5CH2
(IX)
The chemical nature of the toxic substance, designated 
cord factor” and isolated from the wax fraction of tuberclen
bacillus, has been revealed by Noll, Blocl*, Asselineau and
T , 89 89590
Leaerer . The purified sample of cord factor having
m.p. 37-38°, [a]j) + 31°, molecular formula Ci86H3680i7
8 9 /
±10(CH2), was identified as trehalose - 6,6-dimycolate
22
911 92
and this was confirmed by synthesis
The chemistry of other natural constituents of the
93 93 ) 94
purified wax and the acetone-soluble fat has also
been investigated. Such chemical studies have permitted 
both qualitative and quantitative distinctions to be made 
with accuracy in the classification of various strains of 
tubercle bacillus by infrared spectroscopy .
Biological Properties of_ Lipoids.
17 * 96
Investigations carried out by Sabin and her co-workers 
have revealed that formation of typical giant cells and 
epitheloid cells could be provoked not only by dead tubercle 
bacilli but also by their lipoid constituents. Whilst
97 9 98
confirming these results various workers have shown
that the methylated branched-chain acids of the phthioic 
acids type cause the formation of typical epithelioid cells, 
and that laevorotatory acids produce more granulomatous 
lesions than dextrorotatory acids in guinea pigs.
Typical tuberculin hypersensitivity has been demon­
strated by injecting wax fraction from Myco. tuberculosis
99
(human strain) together with tuberculoprotein into guinea
pigs. After testing the various crude and purified
1 0 0
components of wax, it has been concluded that the so-called 
"cord factor’* is responsible for hypersensitivity. The
23
relationship of virulence to cord factor in Mycobacteria.
101
however, has not been substantiated.
PROTEINS.
The study of protein constituents has been found to be 
far more complicated than that of the other constituents of 
the tubercle bacillus, due to the complexity of protein 
macromolecules. The proteins are usually isolated from the 
liquid culture filtrates which in addition to the constituents 
of the medium contain proteins, nucleic acids, carbohydrates 
and bacillary metabolites which have diffused out from the 
bacterial cells. Robert Koch isolated the substance, 
tuberculin, which gave characteristic protein reactions, from 
culture filtrates of tubercle bacilli by precipitation with 
ethanol.
Though the extensive study of various protein fractions
has not provided any new approach to the chemotherapy of
tuberculosis, their immunological properties have been of
considerable value as a diagnostic aid in clinical assessment
13c
of the disease. The tuberculin reaction of Koch , or the
specific allergic reaction, involves the injection of a 
minute amount of tuberculin into the skin of a tuberculous 
animal and is manifested by a zone of inflammation. Numerous 
investigations have been carried out in the past for the
24
isolation of the pure fractions responsible for the
tuberculin reaction.
Fractionation and purification of various protein
components has been achieved as a result of the brilliant
researches of Seibert and these have been summarised in a
5 3 )6 0 )102
number of reviews . The specific protein fractions,
tuberculin, in its crude form is a water-soluble mixture of 
protein, nucleic acid and polysaccharide. The specific 
potent protein known as Old Tuberculin (O.T.) was precipitated
103
from heated culture filtrates with trichloracetic acid ,
104
the latter being washed off subsequently with ether . The 
product which was designated as purified protein derivative
. 105
(PPD), was found to be stable, uniform and effective
PPD was contaminated substantially with nucleic acid and
polysaccharide, though each of these impurities was inactive
in tuberculin reaction. The nucleic acid was separated by
precipitation of the protein at pH7. A standard purified
106
protein derivative (PFD-S) was prepared by ultra filtration 
of the culture filtrate and by precipitating the protein 
repeatedly with neutral saturated ammonium sulphate at pH7. 
This purified product contained 1.2 per cent of nucleic 
acid (diphenylamine reaction) and 5.9 per cent of poly­
saccharide (carbazole reaction) and had a potency twice that 
of the former purified protein derivative. Subsequently this
25
preparation was adopted as the international standard
107 54
tuberculin . Seibert has since indicated that this
purified product contains at least two proteins which show
differences in their solubility, coagulability, diffusibility,
sedimentability, electrophoretic mobility, antigenicity and
potency. Thus the native or undenatured proteins in raw
tuberculin have been designated as proteins A and B. These
proteins are soluble at all hydrogen-ion concentrations but
are differenciated by the fact that protein A has a lower
electrophoretic mobility than the B. The dissociation
constants of the more polar groups in protein B suggest that
they may be imidazole structures.
The denatured proteins A* and B* corresponding to the
native proteins A and B have been identified by precipitation
at pH4 to 5 and show lower potency for eliciting the
tuberculin skin reaction than the native proteins. The two
108
proteins isolated by Bevilacqua and McCarter , have been 
shown to be separate entities and one is not the degradative 
product of the other. Such studies of different protein 
components and their denaturation has led to the use of
109
unheated culture filtrates
More recently Seibert has affected still further
purification of PFD-S by precipitation of unheated culture
110 109 
filtrates with ammonium sulphate and also with ethanol
26
at low temperatures and at controlled pH and salt
concentration. The three groups of proteins designated
as A, B and C in the order of their electrophoretic
111
mobility were fractionated in this way. The least
potent fraction which was obtained by simple precipitation 
at pH4, had the greatest mobility. The fraction B having 
mobility similar to that of fraction C, was precipitated 
with 30 per cent ethanol at pH 4.6. The fraction A 
which was the least mobile, required 70 per cent of ethanol 
at pH 4.6 for its precipitation. This fraction was the 
least homogeneous, being appreciably contaminated with 
carbohydrate. Proteins A and C had similar ultraviolet
109 « p
absorption spectra at 2800 A., but at 2500 A., protein C
had nearly twice the optical density of protein A.
The amino acid constituents of various protein
112
fractions have been studied by Seibert . The A proteins 
showed a higher content of proline, glutamic acid-alanine 
and the basic amino acids, arginine and lysine than that of 
the C proteins while the latter contained more leucine - 
isoleucine, phenylalanine and valine. These differences 
particularly in basic amino acids for which nucleic acid 
has special affinity may explain the difference in absorption 
spectra of these protein fractions.
27
Biological properties of these fractions were 
110)112
studied by Seibert . The fraction A was found
to be most active in tuberculous reaction and particularly
in eliciting antibodies in normal animals. The greater
tuberculin activity of protein A was attributed to the
presence of more phenolic groups than in protein C.
Besides the isolation of protein fractions from culture
filtrates, many investigators have attempted to extract the
biologically active proteins from the bacillary bodies.
113
Heidelburger and Menzel obtained three antigenically 
different protein fractions by treating the acetone- 
extracted cells with dilute acetate buffer under increasingly
114
alkaline conditions. Heckly and Watson extracted the 
mechanically ruptured bacilli with phosphate and borate 
buffers and isolated various protein fractions. More recently
112)115
steam-killed cells were treated with urea and the
116
purified product so obtained, found to be homogeneous 
in its electrophoretic behaviour. It resembled Seibert *s 
C proteins in its ultraviolet and electrophoretic character­
istics but was similar to proteins A in eliciting skin 
reactions in tuberculous animals.
It is evident that certain protein fractions which 
are antigenic, produce a specific reaction in infected 
animals. It has been demonstrated that proteins from
28
different strains of tubercle bacilli elicit a certain
117
amount of immunological specificity. Aronson has
confirmed Kochfs observation that animals previously
infected become resistant to reinfection. This principle
has been applied from time to time in an effort to
produce specific immunizing agents from modified and
heat-killed tubercle bacilli. Tubercle bacilli modified
118
with radium bromide, and with ultraviolet light , protected 
guinea pigs to a certain degree against reinfection.
119
Heat-killed tubercle bacilli increased resistance to 
reinfection with virulent strains. The B.C.G. vaccine, 
a living attenuated bovine strain, on the other hand, has 
been shown to confer greater resistance in both experimental
117 120
and clinical studies . Recently M-vaccine prepared 
from an attenuated murine type strain has been claimed to 
possess manifold advantages over B.C.G. vaccine.
THE CHEMOTHERAPY OF TUBERCULOSIS
Synthetic Tuberculostatics
Little progress was achieved in the chemotherapy of 
tuberculosis in the first three decades of the present
121
century. Until then the older remedies such as creosote,
122
salts of heavy metals particularly of gold and dyes such
123
as methylene blue and its derivatives, were frequently used
29
in combating tuberculosis, though without marked success. 
Their administration, too, was often attended by a marked
risk of toxic side reactions. Cod liver oil and vitamin 
preparations were also used extensively as adjuncts mainly 
because of their beneficial contribution to the general 
health of the patient.
Sulphonamides and Sulphones.
The advent of sulphonamides in 1935 brought the 
opportunity to explore their potentiality in experimental
igg las
tuberculosis. Sulphanilamide, sulphapyridine,
127 128
sulphathiazole, and sulphadiazine showed some activity
against Mycobacterium tuberculosis both in vitro and i|i vivo. 
While these investigations did not warrant the clinical use 
of sulphonamides, they did lead to a new class of compounds, 
namely the sulphones.
129
4,4'-Diaminodiphenyl sulphone (X) (Dapsone), the
130
prototype of this group, was first tested in 1937 and
131
was shown to be active both in vitro and in vivo.
(X)
Its toxicity, however, arrested its clinical use in 
tuberculosis, but Lowe132 found it to be a valuable agent
30
in the treatment of leprosy.
A large number of less toxic derivatives of Dapsone 
were prepared by substitution in the amino group and drugs
13 3
of particular interest have been designated as Promin 
(XI), (disodium 4,4'-diaminodiphenyl sulphone-N,Nf-diglucose
134
sulphonate), Promizole (XII) (4,2'-diaminodiphenyl-
x 135
-5-thiazolyl sulphone), Solapsone or Sulphetrone (XIII) 
(tetrasodium 4,4f-bis-^ / -phenyl-n-propylaminodiphenyl
13 6
sulphone tetrasulphonate) and Diasone (XIV) (4,4'- 
-diaminodiphenyl sulphone disodium formaldehyde sulphoxylate) 
All these compounds were of limited clinical use.
CHa0H-(CH0H)4-CH - NH ^
S03Na
(XI)
SOg
// so, - c ^ o  - m .
HC N
(XII)
CH - CHa - CH - NH 
S03Na S03Na
(XIII)
\  t
S0a
Ji
CHa - NH
I
S03Na
(XIV)
// S02
2L
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Thiosemicarbazone s.
137
Domagk inferred from comparative studies of 
the tuberculostatic activity of sulphathiazole9 sulpha- 
thiadiazole (XV) and promizole that much of the activity 
was contributed by the thiazole ring and as a result of 
this discovery, commenced the examination of structurally 
analogous compounds. He showed that the open chain 
4-acetylaminobenzaldehyde thiosemicarbazone (Thiacetazone
i
XVI, Conteben, Tb ^ 9 3 ) was the most active of the
N  N N—  NH
(XV) (XVI)
substances examined. Its efficiency has been confirmed in
138 139
experimental animals and in clinical trials but due 
to its high toxicity, it could not compete with other 
equally effective tuberculostatics which were to be 
introduced later on.
Para-^ninosnJLicylic Acid (PAS)
140
The work of Bernheim which demonstrated the 
inhibitory effects of benzoates and salicylates on the
141
respiration of tubercle bacilli, prompted Lehmann in 
1946 to test a series of benzoic and salicylic acid 
derivatives against Mycobacterium tuberculosis. Of these,
CH3CO - NH H C - NH2
32
jD-aminosalicylie acid (PAS) (XVII) was found to b® th®
141*142
most active in both experimental and clinical
141*143
studies
COOH
OH
V
nh2
(XVII)
Comparative trials have since shown it to be much 
less active than either isoniazid or streptomycin but 
in combination with either of the latter, drug action is
144)146
reinforced and the emergence of resistant strains delayed
Isonicotinic Acid Hydrazide (Isoniazid ).
The discovery of ja-acetamidobenzaldehyde
137
thiosemicarbazone (XV) by Domagk as an effective
146
tuberculostatic, prompted Fox to synthesise isonicotin- 
aldehyde thiosemicarbazone (XVIII) through the intermediate 
isonicotinic acid hydrazide, (XIX). The latter was 
proved to be a potent chemotherapeutic agent in tuberculosis, 
being much more effective than the semicarbazone.
./“ \  -  - -  -  _  ~/=y~ ch a n - hh - cs - nh2 t/ co.nh.hh2
(XVIII) (XIX)
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After encouraging reports based on in vitro 
experiments, isoniazid was found to exhibit a high level
148 149
of activity in experimental tuberculosis and in man 
and rapidly became established as the most potent anti- 
tuberculous agent. Co-administration with pyridoxine 
has been found to prevent undue toxicity when higher dose
150
levels are required . Like PAS, isoniazid is immediately
151
absorbed after oral administration . In the last few 
years a large number of isoniazid derivatives have been 
examined for tuberculostatic activity but without success.
The antituberculous activity exhibited by nicotinamide
152
and some of its derivatives led to the synthesis of
153
pyrazine analogues . Of these, pyrazinamide (XX) was
154
regarded as promising but has been shown to be unsafe
155
for routine clinical use due to its high toxicity.
s  V
I CONHa 
N (XX)
Surface-Active Agents.
A commercial non-ionic surface-active agent wTriton 
A 2 0 ,! and other similar macromolecular polyoxyethylene ethers
156
were found by Cornforth and others to suppress the 
development of experimental tuberculosis in the mouse and
34
157
this was confirmed by Solotorovsky and Gregory . Increase
in the number of ethylene oxide units from between 1 0 and
20 (with highest activity) to 25 to 30 abolished the
therapeutic activity and with yet further increase to
between 45 and 90 units gave substances which exhibited
158
protuberculous effect . The opinion has been expressed 
that these surface-active agents possibly influence 
tuberculous infections by modifying the surface lipoids of the 
tuberculous bacillus within the monocytes in experimental 
animals.
Hinconstarch
Hinconstarch is a polymer which is prepared from 
periodate oxidised potato starch by condensation with 
equimolar proportions of isoniazid and p-aminobenzalthio-
159
semicarbazone . It is a yellow amorphous powder, insoluble
in water and accordingly its antituberculosis activity has
160
not been investigated in vitro . It was shown, however,
160
to be effective in experimental tuberculosis and in 
161
clinical trials but haemolytic reactions and hepatic 
toxicity limit its usefulness. A further disadvantage 
is the instability of the polymer in the presence of dilute 
acid or alkali.
35
Antibioties
Out of the several antibiotics so far studied for 
antitubercular activity, only a few have passed beyond the 
stage of laboratory experiment due either to high toxicity 
or to diminished activity. Streptomycin one of the first 
antibiotics found to be effective in the control of 
tuberculosis is still used more extensively than any other 
for this purpose.
Streptomycin and its Derivatives
Streptomycin (XXIa) was isolated from Streptomyces
162
griseus in 1944 by Schatz, Bugie and Waksman as a 
result of a long and painstaking search among actinomycetes
163
for antibacterially active metabolic products . Schatz
164
and Waksman demonstrated its activity against Mycobacterium 
tuberculosis in vitro and this was confirmed by Youman and
165 166
Feldman . Tests on experimental animals, and clinical
167
trials soon followed establishing its effectiveness as
168
a bacteriostatic agent in the treatment of a wide variety
of tuberculous lesions. Response to streptomycin is most
169 170 171
favourable in acute miliary , pulmonary and meningeal 
tuberculosis, but chronic fibrotic lesions are little 
affected. A serious disadvantage is the need to administer 
the drug by intramuscular injection due to its poor
36
absorption from the intestine. A farther limiting factor 
to prolonged therapy is the rapidity with which the
172
tubercle bacillus acquires resistance to streptomycin 
This may be obviated, however, by administering jD-amino-
173 174
salicylic acid and isoniazid in conjunction with 
streptomycin, a form of treatment which significantly delays 
the emergence of streptomycin resistance
NH
I NH
HjjN.C.NH I
Streptose
OH 0
CH2OH \  
HSCNH j
N-Methyl
glucosamine
3
Streptidine 
OH
(a) R* = CHO$ R* = R3 = H
(b) R* = CHaOH, R* = R3 = H
2 3
(c) R f = CHO, R = H, R = D-mannose
(d) B' = CHO, B* = OH, B® = H
(e ) B' = COOH, B® = BS = H
(XXI)
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Some toxic effects are produced by prolonged 
treatment with streptomycin. These include impairment 
of renal function, giddiness and allergic manifestations 
though by far the most serious are disturbances of
175
auditory and vestibular function . This neurotoxicity 
was once attributed to the presence of the aldehydic group
176
since it is partly eliminated in dihydrostreptomycin 
Other guanidino-substituted antibiotics also cause 
vestibular disfunction and it is now thought that in 
streptomycin, this is probably associated with the
177
streptidine part of the molecule.
Dihydrostreptomycin (XXIb) which is formed by
1785179
catalytic reduction of the aldehydic group to the
180
corresponding primary alcohol was found in both In vitro
181 182 
and in vivo tests, and also in clinical trials to be
almost as effective as streptomycin against Myco.tuberculosis.
Despite early reports to the contrary, impairment of hearing
mechanism is even greater than with streptomycin. In order to
minimise the appearance of toxic symptoms, the use of both
streptomycin and dihydrostreptomycin in admixture, has been
proposed, so that equilibratory toxicity of streptomycin and
183
auditory nerve toxicity of dihydrostreptomycin are lessened.
Mannosidostreptomycin (Streptomycin B) (XXIc) was 
isolated by Fried and Titus from the crude streptomycin
38
1 85
concentrates and purified by conversion into the
186
reineckate. Structural analysis revealed that the 
molecule consists of streptomycin joined glycosidically to 
D-mannose. Mannosidostreptomycin can be converted to 
streptomycin by the enzyme mannosidostreptomycinase obtained
187
from the cell-free preparations of Streptomyces griseus , 
and the antibiotic is thought to be the precursor of strepto­
mycin. The smaller yield of mannosidostreptomycin compared 
with streptomycin from the culture filtrates lends further
support to this argument. Because it is comparatively less
188
active than streptomycin , it has not been used clinically. 
Hydroxystreptomycin (XXId) has also been isolated
189)190
from various species of Streptomyces . Its
biological activity is comparable to that of streptomycin
1 91
but it exhibits rather high ototoxicity and for this
reason it has not been developed as a practical agent for 
the treatment of tuberculosis.
192
Recently Malek and his coworkers have suggested a 
new and interesting form of streptomycin therapy. They 
have combined streptomycin with polyacrylic and natural 
polycarboxylic acids and with sulphonic and phosphorylated 
polysaccharides to form a series of so-called lymphotropic 
antibiotics. These macromolecular salts act as pure colloids 
which are absorbed by the lymphatic system and become
39
concentrated in lympl^iodes. On the other hand, much 
lower blood levels are achieved than with the parent 
antibiotic but these are maintained for longer periods, 
and consequently excretion is delayed. Acute toxicity 
also is much less than that of streptomycin in experimental 
animals. Similar results have been obtained with 
neomycin, viomycin and other antibiotics.
The Problem of Streptomycin - Resistance
An antitubercular agent should preferably be highly 
bactericidal for the causative organisms in concentrations 
that do not produce toxic symptoms in the host. But even 
the most potent tuberculostatics such as streptomycin, 
isoniazid and p-aminosalicylic acid are bacteriostatic rather 
than bactericidal agents when administered in therapeutic 
doses. This necessitates the prolonged therapy which 
induces the emergence of bacterial resistance.
Very soon after streptomycin became available for 
laboratory experiment and clinical trials, reports of the
1 93 9 1 94
development of streptomycin-resistance began to appear
195
The resistance was also observed during serial sub- 
culturing on media containing increasing concentrations of
1 96
streptomycin. A careful in vitro study revealed that 
streptomycin-resistant variants appeared in the cultures
40
of susceptible strains as a result of random mutations in 
bacterial population. Resistance is, therefore, considered 
to be a heritable character arising possibly by gene
197 196
mutation and this has been confirmed by prolonged
sub-cultivation on streptomycin - free media. One
hypothesis suggests that streptomycin-resistance is somehow
associated with desoxyribonucleic acid but no satisfactory
198
answer has as yet been found
199
Hiller and Bohnhoff observed the development of
streptomycin - dependent organisms. Colonies of E. Coli
grew larger on media containing high concentrations of
streptomycin. These dependent variants were known to be
genetically alike and the larger size was due to direct
stimulation by streptomycin.
Streptomycin-resistant and dependent-strains have been
utilized in the identification of streptomycin-producing 
200
moulds; they have also been used as a tool in bacterial
genetics as well as to explore the mode of action of
i63a
antimicrobial agents. The growth of streptomycin-
163a
dependent meningococci is not stimulated by streptomycin
degradation products such as streptamine, streptidine and
streptobiosamine, by lipositol and inositol or by streptomycin
inactivated with hydroxylamine hydrochloride and cysteine
201
hydrochloride. Rake , however, demonstrated that
41
preparations such as lipositol, N-acetyl-mannosidostrepto- 
mycin and streptobiosamine possessed some activity. This 
facet of the problem, therefore, still requires further 
investigation.
The efficacy of streptomycin would be naturally 
enhanced if the obstacle of streptomycin-resistance could 
be eradicated though in preliminary investigations, 
intermittent administration or combination of streptomycin 
with other tuberculostatics was suggested to delay the onset 
of streptomycin resistance.
The Mode of Action of Streptomvcip.
163b
Henry and Hobby have cited several ways in which
streptomycin might interfere with bacterial metabolism but
little is known with certainty about its mode of action
202 5203
against the tubercle bacillus
The action of streptomycin on the bacterial cell is 
influenced by several factors, namely, concentration of the
204)205 204
antibiotic , the size of the inoculum , the nature
206
of the medium, its pH and the length of time for which 
the cells are exposed to the antibiotic. Thus the efficiency 
of streptomycin decreases with increase in the size of the 
inoculum which is correlated with the presence of greater
p A J
numbers of resistant organisms . Further, the activity is
42
pronounced when the culture consists of young actively 
205
growing cells but is diminished against resting cells
207
or older cultures . This seems to suggest that 
streptomycin blocks the synthesis of bacterial metabolites 
or the process of cell division.
The activity of streptomycin is reduced by inclusion 
in the culture medium, of peptone antyamino acids such as
208
methionine, cysteine, proline, tyrosine and aspartic acids •
209
Cysteine, however, does not inactivate dihydrostreptomycin
and this has been interpreted to imply that the aldehyde
group may not be necessary for the action of streptomycin.
210
On the other hand, Bailey and Cavallito have suggested
that dihydrostreptomycin is first oxidised to streptomycin
by the organism and only then is it inactivated by cysteine.
It has been concluded that streptomycin possibly acts by
interference with amino-acid synthesis at enzyme level.
211
Nevertheless, Henry and others failed to observe inhibition
of purified enzymes with streptomycin.
Streptomycin probably exerts certain growth-inhibitory
effects by virtue of its action on cellular metabolism.
212
Certain cell constituents such as proteins , desoxy-
213 212
ribonucleic acid and lipoids form complex precipitates 
with streptomycin is possibly brought about by the diguanide 
part of the antibiotic, but as a basis of the mode of action
43
203
this is still controversial since the streptidine
fragment does not show any activity. On the other hand,
the surface adsorptive capacity of polysaccharides in the
18
tubercle bacillus has been suggested by Stacey and Kent 
to help in the fixation of streptomycin and thereby modify 
the permeability of the cell.
The inhibition of terminal respiration has been 
interpreted as an important mechanism of the mode of
214
action of streptomycin. Umbreit observed that the 
inhibition of fumarate and pyruvate oxidation by 
streptomycin in E.coli results in a block of the terminal 
respiration system which involves a pyruvate-oxalacetate 
condensation. The nature of this reaction has not been 
fully elucidated but a possible intermediate involved is
215
2-phospho-4-hydroxy-4-hydroxycarbonyladipic acid
216
Oginsky, Smith and Solotorovsky have suggested that 
streptomycin interferes in the oxidation of higher fatty 
acids synthesised by tubercle bacillus and may, thus, block 
the utilization of such materials.
Most of the observations which have bearing on the 
mode of action of streptomycin, have been limited to 
either resting cells, growing cells or isolated enzymes and 
other constituents of the parasite but the superiority of 
anyone over the others has not been demonstrated. Possibly,
44
each factor is responsible for a number of toxic reactions 
that contribute to the therapeutic effectiveness of the 
antibiotic.
The Chemistry and Biological Activity of Streptomycin 
_______ and its Degradative Products*________________
Streptomycin is a laevorotatory, triacidic base with
the molecular composition, C2iH390 i2N7, which does not
crystallise, but which forms a crystalline calcium chloride
complex, 2 (C2 iH390 i2N7.3HC1 ).CaCl2# Other salts of
commercial importance are, the sulphate 2 (C2 iH3 0^ i2N7 )#3H2S04
and the trihydrochloride. The crystalline complex has
proved to be of great value in eliminating impurities in
217
crude streptomycin concentrates, though chromatographic
218
techniques have also been exploited commercially for the
purpose. Other crystalline salts have also been recorded
218
for characterisation and purification of the antibiotic.
Streptomycin is soluble in water and insoluble in almost 
all organic solvents. The hydrochloride is quite soluble in 
methyl alcohol in contrast to the sulphate but both are 
soluble in water. streptomycin is relatively stable at 
pH 1-10 but quite stable at pH 3-7 at temperatures below
219
28°
The chemical investigations which led to the elucidation 
of the structure of streptomycin were carried out principally
45
by Folkers,Wintersteiner, Carter, Wolfrom and their 
respective collaborators. These studies have been
220j22i
reviewed elsewhere . Streptomycin is composed of
three moieties, streptidine, streptose and N-methyl-L-
-glucosamine joined together by glycosidic linkages.
22a
Wolfrom and his coworkers have pointed out that 
positions 4 and 6 of the streptidine moiety (XXI) are not 
configurationally equivalent and that substitution of the 
same optically active streptobiosamine fragment for the 
hydroxyl hydrogens at these points will lead to diastereo- 
isomers. This configurational point in the streptomycin 
molecule remains to be elucidated though hydroxyl hydrogen 
at position 4 is generally accepted to be linked glycosidic- 
ally to streptobiosamine. However, the same authors have 
established that the linkages between streptidine and strept­
ose is 0- and that between streptose and N-methyl-L- 
glucosamine is a- . The latter linkage is comparatively 
stable and requires drastic acidic conditions for its 
cleavage while the former weaker glycosidic bond between 
streptidine and streptose is readily cleaved by acid
223
hydrolysis to give streptobiosamine (XXII) and
2 24
streptidine (XXIIIa). The latter has been shown by 
degradation to be the mesoform of l,3-dignanidino-2,4,5,6- 
tetrahydroxycyclohexane and this structure has been confirmed
46
Streptomycin
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by synthesis. Neither of these hydrolytic products 
either individually or mixed together exhibit any 
antitubercular activity.
The optically inactive, diacidic base, streptidine
47
224
was converted by stepwise alkaline degradation with
barium hydroxide solution, first into strepturea (XXIIIb)
and then to streptamine (XXIIIc). The basic disaccharide
streptobiosamine (XXII) was further degraded by acid
hydrolysis to N-methyl-L-glucosamine (XXIV) whose structure
2 26
was confirmed by synthesis. The instability of
streptose moiety under drastic hydrolytic conditions 
presented considerable difficulties in the elucidation of 
its structure but was finally shown to be 3 -C-formyl-5 - 
-deoxy-L-lyxose (XXV), a pentose containing a reactive
227
aldehyde group
The presence of the aldehydic group in streptomycin
was established by oxidation with bromine to streptomycinic 
228
acid (XXIe ) and by the formation of an oxime, semicarbazone
229
and phenylhydrazone , all of which were biologically
inactive. On the other hand, a low antitubercular activity
has been demonstrated with streptomycylidene isonicotinyl
hydrazine which was obtained by condensation of streptomycin 
230
and isoniazid . The desirable attributes of both drugs 
are thus combined in a single preparation which has the 
added advantage of being devoid of serious toxic effects 
attributable to streptomycin.
Reduction of the aldehydic group to the corresponding
178 231
primary alcohol by hydrogenation with platinum or nickel
48
gave dihydrosterptomycin which showed biological activity
comparable to streptomycin. Dihydrostreptomycin base
*sa
unlike , streptomycin has been crystallised , though it
does not form calcium chloride double salt and is not
178
decomposed by alkali to yield maltol (XXVI).
H
H
CH3 
- OH
(XXVI)
Owing to the relative stability of the dihydrostreptose 
fragment to alkali, it was possible to degrade dihydro- 
streptomycin (XXIb) with barium hydroxide solution first 
to strepturea dihydrostreptobiosaminide (XXVII) and then to
streptamine dihydrostreptobiosaminide (XXVIII). 
derivatives were devoid of antitubercular activity
These
233 9234
NH
li
HaN.C.NH
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EP.C.NH 
NH
HN.C.NHg .C.NH2
(XXIb) (XXVII) (XXVIII)
Since the substitution of guanidino groups in 
dihydrostreptomycin abolishes its activity, the significance
of these groups has been tested by Latham, May and Mosettig
235
49
by synthesising diamino- and diguanidino- phenyl p-D- 
glycosides (XXIX, XXX). But none of these compounds were
OH
OH
R
OH
OH
HHa
R
NH
!i
R = -NH2 or -NH-C-NH2
(XXIX)
NH
I
R = -NH2 or -NH-C-NHa
(XXX)
found to be active in vitro against Myco.tuberculosis.
During the preliminary investigations of streptomycin, 
it was observed that crude concentrates were more toxic to 
experimental animals than streptomycin itself. Further 
purification of streptomycin resulted in the isolation of 
an interesting substance which proved lethal to mice. 
Characterisation, structural determination and synthesis of 
this substance led to the discovery that under certain 
conditions ammonia unites with two molecules of streptomycin 
to form bis-(a-hydroxystreptomycyl )-amine (XXXI) which is
236
much more toxic than pure streptomycin •
OH OH
I I
St - C - NH - C - 'St
I I
H H
St is streptomycin less - CHO.
(XXXI)
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Mannosidostereptomycin (XXIc) is comparatively less
1 8 8
active than streptomycin while hydroxystreptomycin (XXId) 
possesses biological activity comparable with that of
191
streptomycin but it exhibits much higher ototoxicity 
In the past,various attempts have been made to 
modify the structure of streptomycin in order to enhance the 
antitubercular activity or to reduce its toxicity.
237
Jarowski and Murphy have demonstrated that hydroxymethyl 
streptomycin (XXXII) prepared by reaction with formaldehyde 
is comparable in biological activity to streptomycin but its
(XXIa)
1--- 1
HO
OH
(XXXII)
neurotoxicity is significantly lower than that of the latter.
238
Redmond and Cummings have observed that conversion to
0 “] h3c
CHO CH=N.R
OH OH
jV- J
(XXIa)
0— J
OH
(XXXIII)
51
23 9
N-substituted streptomycylamines (XXXIII) by condensation 
with primary amine and subsequent reduction modifies the 
biological activity of streptomycin in three ways. Thus 
not only is tuberculostatic activity decreased but it 
varies with sensitive, resistant and dependent strains 
of tubercle bacilli and antistreptomycin activity also 
appears.
Tuberculostatic activity is completely lost with 
decyl- or dodecyl-streptomycylamine but is only reduced when 
streptomycin is condensed with a shorter chain base such 
as propylamine. Streptomycylamine and some of its derivatives 
such as N *-jD~sulphonamidobenzyl-, N ‘-n-octadecyl-,
N *-2-buto2y-5 -pyridyl-streptoinycylamine and methylolstrepto- 
mycin inhibited the resistant strain at 1 0 p.g per ml. while 
dimethylol N'-n-dodecyl-streptomycylamine antagonised the 
action of streptomycin against streptomycin-sensitive and
23 8
dependent strain
It would appear from structures of the three 
naturally occurring streptomycins and from the biologically 
active derivatives of streptomycin such as dihydrostrepto­
mycin, methylolstreptomyein and streptomycylamines that 
some structural variation is permissible without the 
destruction of the antibacterial properties.
52
Other Antibiotics
Neomycin
240
Neomycin, a complex metabolic product obtained from
241
Streetomvces fradiae * has been shown by chromatography 
to be a mixture of two closely related substances, neomycins
242
B and C (neomycin A is probably neamine, a degradation 
product of neomycins B and C). They resemble streptomycin 
in that a disaccharide unit, termed neobiosamine is linked 
glycosidically to a basic component, neamine (deoxy- 
streptamine ) analogous to streptidine. The formula 
(XXXIV, R = H) for neobiosamines B and C from neomycins
243
B and C (XXXIV, R = C1 SH3 5 N4 O5 ), have recently been proposed 
on the basis of physico-chemical study.
R - 0 - C5H6 (0H)s - 0 - C6H7 0(0H)a(NH2 )2 
D-Ribose Diaminohexose
(XXXIV)
„  244
Neomycin is active against tubercle bacilli in vitro
245
but in clinical tuberculosis its effectiveness is 
associated with serious toxic effects such as renal damage 
and deafness. It is chemically more stable than streptomycin; 
it also appears to induce bacterial resistance at a slower 
rate and is active against streptomycin-sensitive and
34 6-resistant strains . Its toxic symptoms have limited 
its use to topical application and pre-operative sterilization 
of the gut.
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Viomvcin.
247
Viomycin, an antimicrobial agent produced by 
Streptomyces puniceus and StrePtomvces floridae > is a 
polyacidic base with empirical formula Ci8H3 i..3 3 N 9 0 3 . It 
is slightly less potent than streptomycin in tuberculous
248
infections but is also active against streptomycin-
249
resistant tubercle bacilli. Its use in clinical
tuberculosis has been restricted by its toxicity to those
250
cases when neither streptomycin nor isoniazid can be used 
Toxic symptoms such as skin irritation, renal damage and 
vestibular or auditory disfunction can be lessened or 
obviated by suitable selection of dose regimens. As with 
streptomycin, the neurotoxicity is possibly a function of 
the guanidine moiety of the molecule. Solutions of 
viomycin sulphate are moderately stable at room temperature 
and pH 5-6 and are administered intramuscularly.
Cycloserine (Syn: Oxamycin, seromycin)
251
Cycloserine, which is produced by StrePtomvces 
orcMdaceus. is effective against the tubercle bacillus 
both in vitro and in_vivo. It has been proved to be of 
value in experimental and clinical tuberculosis. Due to 
its relative non-toxicity, it has been found valuable as an
25
alternative to streptomycin in acute and chronic tuberculosis.
64
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Recent reports, following its more widespread use, 
indicate that it is not entirely free from toxic side 
effects.
It is excreted in the urine after intramuscular 
administration in greater amounts than when the drug is 
administered orally possibly because cycloserine is
254
unstable in strongly acidic or strongly alkaline media 
It is very soluble in water and is comparatively stable in
255
alkaline solutions. Kuehl and his associates have 
identified it to be D-4-amino-3-isoxazolidone (XXXV).
H2C —  CH
I I ^
0 C = 0 *
\ /
NH
(XXXV)
Kanamycin, an antimicrobial agent from StrePtomvces
256
kanamyoeticus was isolated by Umezawa and associates in 
1957. It has been reported to be effective both in vitro 
and in vivo against Myco.tuberculosis and proved to be 
reasonably non-toxic in experimental animals. Preliminary 
clinical trials indicate that kanamycin exhibited a pattern 
of toxicity similar to that of streptomycin and its 
antituberculous activity upon streptomycin-susceptible and
H2C —  CH.NH8
i i .
0 C— 0
\ /
N
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-resistant tubercle bacilli lias been demonstrated by 
Steenken and others . On the other hand, the emergence
of kanamycin-resistant strains is relatively much faster 
than with streptomycin.
Kanamycin is soluble in water but insoluble in the 
common alcohols. Its aqueous solution is stable at 100®
for thirty minutes at pH 6 to 8 . It is poorly absorbed 
following oral administration but is well absorbed by the 
intramuscular route . On the basis of physico-chemical
evidence, Cron and others have assigned, to kanamycin, 
the structure (XXXVI) as that of a deoxystreptamine-bis- 
-hexosaminide, thereby establishing a formal relationship 
with streptomycin.
NH;
OH
OH HOCH;
HO OH
OH
OH
(XXXVI)
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INTRODUCTION
Although the action of streptomycin has been studied 
with many different organisms, it is clear from the preceding 
introduction that the mechanism of its action against 
Mycobacterium tuberculosis is only incompletely understood. 
Little, too, is known of the relationship between the chemical 
structure of streptomycin and its biological activity, though 
the examination of modified structures against specified micro- 
-organisms can provide useful points to their mechanism of 
action.
Considerable interest attaches to the function of the 
streptose aldehydic group since reaction with carbonyl reagents,
22 9
such as hydroxylamine, phenylhydrazine and semicarbazide, with
228
cysteine, or oxidation to corresponding acid leads to 
products which are inactive against Myco.tuberculosis.
23 0
Streptomycin isonicotinylhydrazone is an exception and has a 
significant level of tuberculostatic activity, but this is 
attributed to the isonicotinylhydrazine moiety of the molecule. 
On the other hand, the retention of full tuberculostatic 
activity by dihydrostreptomycin, in which the aldehyde group of 
streptomycin has been reduced to the corresponding primary 
alcohol conflicts with the evidence of the aldehyde group's
importance for activity. However, despite reports to the
209 210
contrary , Bailey and Cavallito , have shown that like
streptomycin, dihydrostreptomycin is also inactivated by 
cysteine. In their view, dihydrostreptomycin is oxidised by
57
the micro-organisms to streptomycin and it would not be 
unreasonable, therefore, to suppose that dihydrostreptomycin 
depends upon such an oxidation for its activity. The related 
streptomycylamines (XXXIII) also show a wide range of 
antibacterial activity, though, in general, it is lower than 
that of streptomycin, but nothing is known either of their mode 
of action or of their possible inactivation by such substances 
as cysteine.
Part of the present work has been concerned with the
preparation of dihydrostreptomycin derivatives in which the
primary alcoholic group (XXIb) is blocked to prevent its
oxidation. Comparison of the tuberculostatic activity of
such derivatives should provide a means of substantiating the
210
conclusion of Bailey and Cavallito and establishing 
unequivocally the importance of the streptose-aldehyde 
function as a factor contributing to the activity of the 
molecule as a whole. The choice of a suitable blocking group 
posed a number of problems. Ideally, this group should be, 
at least, moderately stable, and conversion of the particular 
hydroxyl group to an ether link appeared to offer the best 
possibility of success. Both streptomycin and dihydrostrepto­
mycin are, however, polyhydroxy compounds and protection of 
the remaining hydroxyls by groups which could be readily 
inserted and equally readily removed was a prime requirement 
of any synthetic route. This, coupled with the known
58
instability to acid of the streptose-streptidine link in 
streptomycin and of the dihydrostreptose-streptidine link in 
dihydrostreptomycin, placed a severe limitation on the choice 
of test compound. A further limitation was also imposed by
the known instability of streptomycin to alkali which readily
260
degrades it to maltol (XXVI). Dihydrostreptomycin is stable
178
in this respect but the guanidine groups are unstable to 
strong alkali, when strepturea dihydrostreptobiosaminide
(XXVII) and ultimately streptamine dihydrostreptobiosaminide
(XXVIII) are formed.
The preparation of N-acetyltrityldihydrostreptomycin
(XXXVIIIa), therefore, represents a compromise which is
recognised as departing from ideality in at least two respects.
261
The trityl ether link is cleaved by aqueous acid and probably 
has no greater stability than that of the dihydrostreptose- 
-streptidine link while its stability to alkali permits the 
easy removal of all acetyl substituents except one (N-methyl- 
-N-acetyl). The retention of this group in the final product 
follows from the restriction to mild de-acetylation conditions 
(ammonia-methanol at 0 ^)  imposed by the presence of guanidino 
groups.
The disadvantage of a test compound in which the
N-acetyl group is retained on the N-methyl-L-glucosamine
fragment, is perhaps not so serious as would first appear.
The addition of formaldehyde to streptomycin gives the
237
N-hydroxymethyl derivative (XXXII) which is claimed to
59
exhibit biological activity comparable with that of the 
parent compound. Furthermore, it is less liable to induce 
neurotoxicity# The choice of N-acetyltrityldihydrostrepto- 
mycin as the test compound, however, required that it 
should be compared with N-acetyl-dihydrostreptomycin and 
N-acetylstreptomycin.
N-Acetyltrityldihydrostreptomycin was prepared from 
streptomycin as outlined in the scheme on next page.
AcejLylation of DjJaydrost-re_E-tomycin and Streptomycin 
Sulphates.
Acetylation was used to protect the hydroxyl groups 
in streptomycin prior to tritylation rather than benzoylation 
since octabenzoylstreptidine (XXXIXa) yields a monobenzoyl- 
streptidine when treated with sodium methoxide in pyridine- 
-methanol solution and complete debenzoylation can only be 
accomplished by refluxing with 6 N hydrochloric acid. The 
latter condition would cleave the glycosidic linkages and 
this method was, therefore, considered unsuitable. Octa-
acetylstreptidine (XXXIXb), on the other hand, had been 
NH
RHN.C.NR NH
B
(a) R = C0.C6H8
(b) R = CO.CH3
OR
(XXXIX)
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HN.C.NHa
OH HO
OH
'R = CHO
(XXIa)
AcHN.C.N&c
.C.NHAc
HaQAc Ad 
CH0.N
(a) R = CHO
(b) R = CHaOH 
(c ) R = CHaQAc
(d) R = CHaO.C. (C6H5 )3
QAc (XXXVII)
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li
HaN.C.NH
aOH A 
CH3.N
Lo NOE
NH
I
HN.C.NHa
(a R = CH20.C.(C6H8fe(b) R = CHaOH(c) R = CHO
(XXXVIII)
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deacetylated completely at room temperature in
methanolic ammonia. So, on these grounds, acetylation
offered a more suitable alternative route.
Streptomycin and dihydrostreptomycin were available
as sulphates and a preliminary investigation was carried
out to see whether these salts could be acetylated directly
to the corresponding undeca-aeetyl and dodeca-aeetyl
derivatives. Dodeca-acetyldihydrostreptomyein (XXXVIIc )
had previously been prepared only from the corresponding
222
free base by two stage acetylation with acetic anhydride-
pyridine. Attempts to acetylate dihydrostreptomycin
sulphate by this method were unsuccessful.
The free base was, therefore, prepared by deionization
(de-acidite F.F. ) of aqueous dihydrostreptomycin sulphate
solution, isolated by freeze-drying and acetylated by
222
Wolfrom s two stage procedure. Later, the tedious 
deionization and freeze-drying procedure was found to be 
unnecessary and dihydrostreptomycin sulphate was acetylated 
directly in the presence of fused sodium acetate which in 
addition to being a base catalyst, helped in the removal of 
sulphate ions as sodium sulphate. A much better yield 
(75-80 per cent) of analytically pure dodeca-acetyl dihydro­
streptomycin was obtained by repeated precipitation from 
benzene-petroleum ether (b.p. 80-100'°) than the chromato- 
graphic purification which gave a very low yield.
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Streptomycin sulphate was also acetylated similarly 
to undeca-acetylstreptomycin (XXXVIIa) m.p. 168-170° (decomp.),
-64.5° (c.,1.1, chloroform).
Hydrogenation of Undeca-acetylstreptomycin.
Attempts to hydrogenate undeca-acetylstreptomycin to 
undeca-acetyldihydrostreptomycin (XXXVTIb) at a platinum 
catalyst in methanol or ethanol failed completely, starting 
material being recovered in each case. However, the 
aldehyde group was slowly reduced when glacial acetic acid 
was used as the solvent, hydrogenation being complete in 
about eighteen hours at room temperature. Completion of 
the reaction was confirmed by testing the product with 
Fehling's solution which was not reduced on boiling.
The influence of solvent in the hydrogenation of
263 264
bases has been explained by Maxted and Walker and others .
Nitrogenous aromatic bases undergo catalytic 
hydrogenation in solution over platinic oxide at a 
considerably lower rate than, for instance, benzene under 
similar conditions. Hydrogenation of these bases is 
facilitated by using either an acidic solvent or the 
hydrochloride instead of the free base.
263
Maxted and Walker attributed this slow hydrogenation 
to a self-poisoning effect of pyridine (XL) and piperidine 
(XLII). They suggested on the basis of their experimental
63
data that the free Electron pair on the nitrogen atom of
pyridine and piperidine leads to a strong adsorption by
the metallic catalyst. This self-poisoning effect vanishes
+ +
c c
.• /•
N*
• 9
(XL)
* N* i
E
(XLI)
i i
9
N •» •* i
(XLII)
1
. n ;
H ‘ * H
(XLI11)
with the addition of mineral acid, the free electron pair 
being shielded by a proton in the corresponding pyridinium 
(XLI) and piperidinium (XLIII) ions. Kinetic studies by
264
Devereux, Payne and Peeling have shown that "unshielded” 
nitrogen atoms in association with an aromatic ring as in 
pyridine (XL) and M-dimethylaniline (XLIV), do not exert 
toxic effects and that these are only exhibited by saturated 
systems as in piperidine (XLII) and NN-dimethylcyclohexyl- 
amine (XLV). Thus catalyst poisoning observed with
ch3 ch3
: if: ch3 : n : ch3
N X
(XLIV) (XLV)
pyridine and other aromatic bases results from the formation
64
of saturated bases in the course of hydrogenation.
Undeca-acetylstreptomycin, like octa-acetylstreptidine
262
(XXXIXb) which is capable of forming a dihydrobromide , 
acts as a base having "unshielded” nitrogen atoms in the 
guanidine groups adjacent to a saturated system (XXXVIIa).
j ’
n;h
n :h
Ac.N.C.N.Ac
.cN.C.NH. Ac
Ac
GAc
OAc
Consequently the availability of nitrogen lone electron 
pairs in undeca-acetylstreptomycin for co-ordinate-bond 
formation with a platinum catalyst, could account for its 
failure to hydrogenate in methanol or ethanol and would 
explain the successful use of glacial acetic acid.
The resultant undeca-acetyldihydrostreptomycin was 
characterised by conversion to the known dodeca-acetyldihydro 
streptomycin.
Tritvlation of Undeca-acetyldihydrostreptomycin.
Although triphenylmethyl ethers may be synthesised 
either (a) from tritanol by reaction with an alcohol in the
65
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presence of an acid catalyst or (b) from triphenylmethyl
261
chloride by reaction with an alkoxide or (c) from
266
triphenylmethyl chloride and an alcohol , the tritylation 
of carbohydrates is commonly carried out by the last method.
(a) (C6H5 )3 C.0H + ROH (C6H5 )3 C.0R + H20
(b) (C6H5 )3C.C1 + R O K  ► (C6H5 )3C0R + KC1
(c) (C6H5 )3C.C1 + ROH (C6H5 )3C.0R + HC1
where R is an alkyl or aryl radical.
Many carbohydrates and in particular their acetylated
derivatives are soluble in pyridine. Dry pyridine was,
266
therefore, a most suitable solvent for the reaction which 
is, consequently, applicable to acid sensitive substances such 
as glycosides. Moreover, pyridine helps in the removal of 
hydrogen chloride liberated in the reaction by formation of 
pyridine hydrochloride. The velocity of tritylation reaction
267
is influenced by the hydroxyl containing component and 
the temperature which may vary in the case of primary hydroxyl 
groups from several days at room temperature to a few hours
266 269
at a higher temperature. Hockett, Fletcher and Ames 
have investigated the velocity of tritylation quantitatively. 
With four moles of triphenylmethyl chloride at room temperature, 
half tritylation was achieved after fifty eight hours and 
with eight moles of triphenylmethyl chloride, slightly better 
results were obtained.
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Undeca-acetyldihydrostreptomycin was therefore, 
tritylated in pyridine at room temperature for eight days 
using eight moles of triphenylmethyl chloride. In 
preliminary experiments much lower yields were obtained when 
tritylation was carried out with four moles of triphenyl­
methyl chloride or for shorter times. The residue remain­
ing after removal of pyridine in vacuo and washing with 
ether, was dissolved in chloroform. After keeping in the 
refrigerator for two hours, crystals of pyridinium triphenyl-
270
methyl chloride (XLVI) (m.p. 172-173°) were separated.
X Nvl +N T N
(C6H5 )3C.C1“ H.C1 1
(XLVI) (XLVI I)
At this stage pyridine hydrochloride (XLVII), which is 
sufficiently acidic to de-tritylate the product in polar
271
solvents, could not be washed off either with water or
cold solution of sodium bicarbonate because the solubility
of the trityl ether of undeca-acetyldihydrostreptomycin 
(XXXVIId) was found to be greater in water than in chloroform. 
The crude amorphous product was, therefore, obtained by 
precipitation from chloroform-ether and dried in vacuo.
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The amorphous product was deacetylated by
dissolving in dry methanol previously boiled and cooled to 
remove dissolved carbon dioxide and immediately saturating 
the solution at 0° with ammonia* This method avoided the 
possibility of de-tritylation, since alcoholysis of trityl 
ether occurs very rapidly in polar solvent under acidic
271
conditions . After twenty four hours at room temperature,
the solution was evaporated in vacuo and the residue was
washed with ether to remove the decomposition products of
pyridine hydrochloride and pyridinium triphenylmethyl
chloride, such as pyridine, triphenyl carbinol and triphenyl- 
270
methyl amine . The residue was, then thoroughly triturated
262
and washed with chloroform to remove acetamide . The 
separation of ammonium chloride formed from pyridine 
hydrochloride during deacetylation, was affected by 
dissolving the chloroform-washed residue in NN-dimethyl 
formamide and filtering off the insoluble salt. The crude 
deacetylated product was recovered from NN-dimethyl formamide 
by precipitation in ether.
At this stage N-acetyltrityldihydrostreptomycin 
(XXXVIIIa) was likely to be contaminated with N-acetyl- 
dihydrostreptomycin (XXXVIIIb) and purification was achieved 
by chromatography in ethanol on a column of neutral alumina 
previously washed with methanol and ethanol. Elution with
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ethanol, with ethanol-methanol and finally with methanol, 
was very slow and was followed spectrophotometrically by 
the observation of optical density of the eluates at 260 m^ i. 
Elution with methanol-ethanol gave a series of fractions 
which showed varying optical density at 260 nyi. The 
eluates collected with 2 0 per cent methanol in ethanol 
gave a residue showing the most intense maximumat 259 nyi, 
and although this product could not be crystallised, it 
was found to be analytically pure. Ascending paper
2 V 3
chromatography using 2.5 per cent jD-toluene-sulphonic 
acid in butanol saturated with water gave Rf values of 
0.34 for N-acetyldihydrostreptomycin and 0.16 for its 
trityl ether. The ultraviolet absorption maximum of 
N-acetyltritylaihydrostreptomycin at 259 mp. had a molecular 
extinction coefficient of 974.7. This is in good agreement 
with the observed value 1010.3 obtained by summation of the 
maximum at 260 mp of triphenylmethyl chloride ( ^ max# = 770) 
and absorption at 259 my of N-acetyldihydrostreptomycin 
({■ = 240.3). Further confirmation of the product as 
N-acetyltrityldihydrostreptomycin was obtained from analysis 
of its picrate.
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Deacetylation of Dodeca-acetyldihydrostrePtomvcin and 
Undeca-acetylstreptomycin.
A strict comparative study of the biological activity 
of N-acetyltrityldihydrostreptomycin necessitated the 
preparation of N-acetyldihydrostreptomycin (XXXVIIIb) and 
N-acetylstreptomycin (XXXVIIIc). The deacetylation of 
dodeca-acetyldihydrostreptomycin (XXXVIIc ) and undeca- 
acetylstreptomycin (XXXVIIa) was accomplished in dry
262 5272
methanol at 0 ° saturated with dry ammonia . After
keeping at room temperature from 18 to 24 hours, the
solution in both cases was evaporated to dryness in vacuo.
The residue was washed with chloroform to remove acetamide
yielding an amorphous product contaminated with a small
262
amount of the carbonate . The insoluble carbonate was 
filtered off from the methanol solution which afforded 
amorphous N-acetyldihydrostreptomycin as well as N-acetyl- 
streptomycin on pouring into dry ether.
The N-acetyl derivatives are analogous to N-hydroxy-
23 7
methylstreptomycin (XXXII), which has a biological 
activity comparable to streptomycin. Since the neurotoxicity 
was found to be significantly decreased in N-hydroxymethyl- 
streptomycin, it would also be interesting to assess the 
toxic manifestations of N-acetyl derivatives.
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The high resistance of the N-acetyl group to 
hydrolysis by methanolic ammonia is of interest. Other
274
deacetylating agents such as methoxides of sodium ,
275
potassium and barium , and even stronger alkalis, such
276
as, barium hydroxide and sodium hydroxide have also been 
demonstrated to produce N-acetylglucosaminides from their 
fully acetylated derivatives. But recently Baker, Schaub
277
and Kissman have achieved N-deacetylation by refluxing
N-acetyl nucleosides with 0.5 N barium hydroxide at 100*.
Under these drastic alkaline conditions, N-acetylstrepto-
mycin is, undoubtedly, degraded to yield streptamine and 
260
maltol
The relative stability of the N-acetyl group to 
alkaline hydrolysis compared with the 0-acetyl group, has
2 7 8
also been observed with acidic reagents when more 
vigorous conditions are necessary for N-deacetylation than 
0-deacetylation. Acidic hydrolysis of other 0-alkylglyco- 
sidic derivatives of 2 -acetamido-2-deoxy-D-glucose has also
279
been investigated. Thus Moggridge and Neuberger demon­
strated that methyl (3-D-glueosaminide (XLVIII) is hydrolysed 
much more slowly by acid than N-acetyl methyl 0-D-glucos-
aminide (XLIX), in which the nitrogen atom carried no charge.
280
Recently Foster, Horton and Stacey -have investigated the
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CHaOH
0 OCHa
OCHs
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HO HO
+
HN.CO.CH3hh3 Cl
(XLVIII) (XLIX)
acid hydrolysis of glycosidic derivatives of 2 -amino-2 - 
-deoxy-glucose. They have demonstrated that incomplete 
glycosidic hydrolysis was due to the existence of two 
reaction pathways which are influenced by the glycosidic 
and the N-substituents. However, the acid hydrolysis of 
methyl 2 -acetamido-2-deoxy-a-D-glucopyranoside (L) was 
found to occur by both pathways, A and B as the final 
hydrolysate, on chromatography, showed the absence of the 
initial glycoside (L) and the presence of components 
corresponding to 2-amino-2 -deoxy-D-glueose (LIII) and methyl
2-amino-2 -deoxy-CL-D~glucopyranoside (LII) respectively.
The slow hydrolysis of compound (LII) to compound (LIII) is
influenced by the positive charge on the basic group and
conforms to the general rule that a-glycopyranosides are
286
more resistant to acid hydrolysis than their (3-anomers.
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It is evident, therefore, that on these grounds 
alone, any attempt to remove the N-acetyl group in 
N-acetyl dihydrostreptomycin or N-acetylstreptomycin under 
either alkaline or acidic conditions, would in all 
probability result in cleavage of the a-L-glucosaminide 
linkage. Even greater instability of the (3-L-strepto- 
biosaminide linkage under acid conditions and the instability 
of streptose and also the streptidine-guanidino groups to 
alkali have already been discussed.
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Synthesis of Streptidine Glycosides.
Whilst the aldehyde group of streptose is, undoubtedly,
important for biological activity, the probable role of the
strongly basic guanidino groups has also been subjected to
206
investigation. Abraham and Buthie examined the
influence of pH of the test media upon antibacterial activity
of streptomycin and observed that the biological activity
of streptomycin decreases with increase in the acidity of
the medium. From this they concluded that the antibiotic
in its cationic form, possibly, competes with hydrogen ions
for the same sites on the bacterial cells. On the other
hand, basic degradation products of streptomycin such as
streptidine and streptobiosamine are reported to be
282 283
biologically inactive either individually or in admixture • 
Streptobiosamine which comprises the basic N-methyl-L-glucos- 
amine linked glycosidically to streptose and thus incorporates 
the important aldehyde group, is inactive and this may be 
attributed to the lack of the strongly basic streptidine 
units.
284
Stenlake has suggested that the streptobiosamine 
fragment of streptomycin is merely responsible for concentrat­
ing and possibly orientating streptidine at the required site 
of action. This hypothesis is supported by the evidence of 
aminohexoses, possibly, D-glucosamine as constituent unit of
74
both the lipoid-bond and somatic polysaccharides of
3 S ? 4 2
Mycobacteria tuberculosis . This, too, is apparently 
underlined by the structures of the antituberculous
343 359
antibiotics such as neomycin and kanamycin (XXXVT) 
which are derivatives of deoxystreptamine (LIV).
NHa
HO OH
OH
(LIV)
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Wolfrom and Polglase degraded dihydrostreptomycin 
trihydrochloride with barium hydroxide solution to 
streptamine dihydrostreptobiosaminide (XXVIII) which in its 
crude form contaminated with barium chloride, was said to 
be inactive biologically. Since the commencement of this 
work, a further communication on the same subject by
334 385
Bodanszky has become available in which both strepturea 
dihydrostreptobiosaminide (XXVII) and streptamine dihydro­
streptobiosaminide (XXVIII) are shown to be inactive. The 
same compounds have been prepared during the present work
334,286
independently of Bodanszky by the controlled hydrolysis 
of dihydrostreptomycin with barium hydroxide in a series of
75
experiments to establish; conditions for the degradation 
of streptidine glucosaminide (IXI).
The diamino— and diguanidino— phenyl glueosides 
(XXIX) and corresponding glucosaminides (XXX) have been
235
synthesised and found to be ineffective in vitro against 
Myco- tuberculosis but the respective streptidine and 
streptamine glycosides have not been examined.
During the present investigation, streptidine (3—ID— 
—glueoside (LVIII) and streptidine p-D-glucosaminide (LXI) 
have been synthesised from hepta-acetylstreptidime 
dihydrobromide (LV) and O-acylglycopyranosyl bromides as 
outlined in the scheme on page 76.
Heuta—acetylstrentidine Dihvdrobromide
Dodeca-aeetyldihydrostreptomycin (XXXVIIc) was 
hydrolysed at about 0° with 31 per cent solution of
2 8 V El
hydrobromic acid in glacial acetic acid • Eepta— 
acetylstreptidine dihydrobromide (IV) was deposited slowly as 
a. sticky residue. It was observed that if the solution 
was kept at room temperature, a very slight residue was 
deposited which did not increase even upon cooling. Attempts 
to isolate the hydrolysis products by chromatography with 
various solvents using charcoal, celite and mixtures of 
these, were without success.
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After decanting the chloroform solution, the
residue was washed with absolute chloroform to remove
unhydrolysed dodeca-acetyldihydrostreptomycin and then
with ether to further effect removal of excess of acidic
reagents* The residue so obtained was still found to be
contaminated with the reactants. Consequently, the
excess of acids were removed by repeated addition and
evaporation of chloroform, and, finally by drying the
residue in vacuo over potassium hydroxide. The decolourised
methanolic solution of the dried residue afforded a white
hygroscopic micro-crystalline precipitate when slowly stirred
into dry ether. The precipitate was washed with dry ether
and then with absolute chloroform to remove any trace of
dodeca-acetyldihydrostreptomycin and finally with dry ether.
The dried sample, m.p* 180-133® (decomp.) was found to be
optically active and in this respect resembled heptabenzoyl- 
262
streptidine . Hepta-acetylstreptidine dihydrobromide was
confirmed by conversion to hepta-acetylstreptidine with
silver oxide and also by acetylation in pyridine with acetic
288
anhydride, to octa-acetylstreptidine (XXXIXb). Hepta- 
acetylstreptidine dihydrobromide was also obtained from 
undeca-acetylstreptomycin (XXXVIla) by the same method.
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Q.~Ac e t y lg lyc opy ranosy 1 Bromides*
O-acetylglycosyl halides have been extensively 
employed in the synthesis of glycosides in preference to 
O-benzoylglycosyl halides because of the ease with which 
they can be prepared and deacetylated. The stability of 
O-aeetylglycosyl halides decreases in the order, fluorides, 
chlorides, bromides and iodides. The fluorides can be 
stored for long periods without decomposition whereas 
iodides decompose even at 0 °. The reactivity of 
O-acetylglycosyl halides, on the other hand, is in the 
reverse order to that of their stability. Since iodides 
decompose too easily and fluorides react with great 
difficulty, bromides and chlorides are most commonly employed.
289
Consequently tetra-O-acetyl-a-D-glucopyranosyl bromide 
(LVI) (acetobromoglucose), tri-0-acetyl-2-amino-2-deoxy-a-D-
290,291
glucopyranosyl bromide hydrobromide (LIX) (acetobromo-
glucosamine hydrobromide), tri-0.-acetyl-2 -methylamino-2 -deoxy- 
-a-D-glucopyranosyl bromide hydrobromide (LXII) and tri-0.- 
-acetyl-2 -me t hylamino-2 -de oxy-a-L-gluc opyranosy1 bromide 
hydrobromide (LXIII) have been prepared as intermediates in 
the synthesis of streptidine glucosides.
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C H 3 .NH.HBr
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AcO CHgOAc
CH 3 NH
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In the cyclic form of aldose sugars, the hemiacetal 
hydroxy group on the anomeric carbon atom has a greatly 
enhanced reactivity over that exhibited by the primary 
and secondary alcoholic groups. This reactivity is 
attributed to spatial asymmetry and by the nature and 
relative positions of the groups on the neighbouring carbon 
atoms. By the proper choice of reagents, such groups as 
hydroxy, halogen, acyloxy, alkoxy, nitrate, phosphate and 
sulphate may be substituted for each other on the reducing 
carbon of acetylated sugars. In the preparation of aceto-
bromoglucose , therefore, the acetoxy group on the reducing
replaced by bromine using hydrobroraic acid in glacial acetic
287a
acid , the substitution being accompanied by a Walden 
inversion.
The prolonged action of hydrogen bromide on penta-O.- 
acetyl (3-D-glucopyranose has been reported to produce 
dibromide by replacement of acetoxy groups at C(i) and C(6 ),
carbon of penta-0-acetyl-(3-D~glucopyranose
287b
(LXIV) was
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CHgOAc
OAc
>Ac
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OAc
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but this can be largely avoided by careful control of the
292
reaction time
Other reagents have also been employed for the 
preparation of (3-D-acetylglycosyl halides. The reaction of 
liquid hydrogen fluoride with acetylated sugars yields
2 93
0-acetyl-glycosyl fluorides , and phosphorus pentachloride
2 94
and aluminium chloride in chloroform are suitable for 
preparation of the corresponding chlorides. Lemieux and
2 95
Brice have shown that penta-O-acetyl-p-D-glucopyranose 
reacts rapidly with titanium tetrachloride to form tetra- 
O-acetyl-glucopyranosyl chloride (LXV) which rearranges to 
its a-anomer (LXVI).
CHaOAc
ClOAc
OAc
AcO
OAcOAc
OAc 'Cl
AcO
OAc
(LXIV) (LXV) (LXVI)
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2 96
The use of acetyl chloride for the preparation 
of C)-acylglycosyl halide has not gained importance because of 
the difficulty in controlling the reaction. However, acetyl 
bromide has been employed successfully for the preparation 
of tri-0-acetyl-2-amino-2-deoxy-a-D-glucopyranosyl bromide 
hydrobromide (LIX) since it permits acetylation without
2 90
H-acetylation. Irvine, McNicoll and Hynd treated D-gluco- 
samine hydrochloride (LXVIl) with acetyl bromide at 60°
2 91
for thirty minutes whereas Fodor and Otvos conducted the 
same reaction at 25-30° for three days, obtaining thereby 
analytically pure acetobromoglucosamine hydrobromide (LIX).
OHHO
-HOI
AcO\.PAo Br
(IX7II) (BIX)
It has been observed in the present work that 
much less decomposition of the product occurs by following
2 91
the procedure of Fodor and Otvos and that old samples of 
acetyl bromide reacted vigorously initially but ultimately 
caused extensive decomposition of the product. This is, 
possibly, due to the presence of traces of water in the 
acetyl bromide owing to its hygroscopic nature.
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The method of Fodor and Otvos was adopted for the 
preparation of tri-0.-acetyl-2-amino-2-deoxy-a-D-glucopyranosy; 
bromide hydrobromide (LIX), tri-<0-acetyl-2-methylamino-2- 
-deoxy-a-D-glucopyranosyl bromide hydrobromide (LXII) and 
tri-0-acetyl-2-methylamino-2-deoxy-a-L-glucopyranosyl 
bromide hydrobromide (LXIII) from 3>-glue os amine hydrochlor­
ide (LXVII), a-D-N-methylglucosamine hydrochloride (LXVIII) 
and a-L-N-methylglucosamine hydrochloride (LXIX) respectively.
In the formation of O-acetylglycosyl halides, two 
anomers are possible. Most of the stable O^acetylglycosyl 
halides in the aldohexoses have the a-D- configuration while 
with many aldopentoses, the stable forms have the (3-D- 
configuration. Based on conformational studies, Hassel and
2 97
Ottar have advanced a theory to explain the greater
CHgOH
CH3 .NH.HCl CH3 .NH.HBr
(LXII)(LXVIII)
CH*0£g \ 
>Ac
(LXIII)
V 1
0
Br
HBr
(LXIX)
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stability of one of the two anomeric forms of 0,-acetyl-D- 
-glucopyranosyl halides. Theoretically, the pyranose ring 
is capable of eight strainless ring conformations, six boat 
and two staggered or chair forms. On the premise that the 
boat form of cyclohexane is considerably less stable than 
the chair form, the boat forms can be neglected and one 
of the two chair forms (LXX, XXXI) will be favoured, 
a a a
e
(LXX)
e
a
(LXXI)
In the O-acetylglycopyranosyl halides, the anomers 
in which the relative position of the halogen (X) on C(i) 
and the larger group (-CH2 OH) on C(5 ) can be represented 
in the two chair forms by
-X*, -CH2C&Ce_ -CHgC&c^
is more stable than the anomer which can be represented by 
-Xe, -CH2C&C£ v=^ -2a, -CHaQAOa
where e_ and a. refer to the equatorial or axial positions of 
the substituents.
Thus O-acetylglycosyl halides of the hexoses show a 
strong preference for the a-1 , 5-trans configuration. This
84
behaviour which governs the stability of the anomeric
2 98
halides is known as Hassel-Ottar effect • The stability
2 9 9
is, thus, correlated with the conformations of a-D- 
and a-L-.0-acetylglucopyranosyl bromides.
As pointed out earlier (page 78), 0.-acetylgluco- 
pyranosyl bromides are less stable than the corresponding 
chlorides and fluorides. Likewise, acetobromoglucosamine 
hydrobromide has been reported to decompose slowly at room
235
temperature . Consequently all the .O-acetylglucopyranosyl 
bromides prepared during the present work were used in the 
synthesis of glycosides as soon as possible after their 
preparation.
Condensation of Hepta-acetylstreptidine Dihydrobromide and 
O-acetylglycopyranosyl Bromides.
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The Koenigs-Knorr reaction which is widely used for 
the synthesis of glycosides, consists of the interaction of 
a substance containing a free hydroxyl group with an 
acetylglycosyl halide in the presence of an "acid acceptor” 
to speed up the reaction and prevent the deacetylation of the 
product.
Normally under the conditions of the Koenigs-Knorr 
reaction when an .O-acetylglycosyl halide reacts with a free 
hydroxyl group, Walden inversion occurs. Since the
85
0.-acetylglycopyranosyl halides used during the present work 
belonged to the alpha-series, the linkages formed in the 
glycosides prepared by the Koenigs-Knorr reaction using 
silver salts were, therefore considered to be of the 
beta-configuration.
Hepta-acetylstreptidine dihydrobromide and the 
respective 0.-acetylglycopyranosyl bromide in equimolecular 
proportions were dissolved in NN-dimethyl-formamide. After 
the addition of each substance to the solvent, the flask was 
evacuated to ensure the removal of traces of moisture from 
the reaction mixture. Silver oxide and quinoline were then 
added simultaneously and the water liberated during the 
reaction was removed under continuous high vacuum along with 
NN-dimethyIformamide. When necessary, moreNN-dimethyl
formamide was added to keep the reactants in solution during 
the reaction. The general reaction may be represented as 
on page 8 6 .
After the reaction was completed, the excess of 
NN-dimethyIformamide was distilled off in high vacuum* The 
semi-solid mass was triturated and washed with dry ether to 
remove unreacted 0_-acetylglycopyranosyl bromide and quinoline, 
the latter having been added to act as a catalyst during the 
course of the reaction. The residue was, then, extracted
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with absolute chloroform which dissolved the (3-glycoside 
only since hepta-acetylstreptidine was found to be 
insoluble in absolute chloroform. The chloroform extract 
in each case was dark red in colour and seemed to contain 
some colloidal silver. The silver salts were removed as 
silver sulphide by passing hydrogen sulphide into a 
cold chloroform solution of the glycoside. Further 
purification by chromatographic adsorption was attempted 
but without success. The chloroform extract was redissolved 
in acetone and decolourised with charcoal. The acetone
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solution on pouring into ether or petroleum ether (b.p. 
40-60°) afforded either an amorphous or in some cases 
microcrystalline precipitate.
By following the general series of reactions four 
glycosides were prepared from hepta-acetylstreptidine 
dihydrobromide (LV), namely undeca-acetylstreptidine (3-D- 
-glucopyranoside (LVII), deca-acetylstreptidine 2-amino-2- 
-deoxy-p-D-glucopyranoside (LX), deca-acetylstreptidine 
2-methylamino-2-deoxy-(3-D-glucopyranoside (LXXII) and 
deca-acetylstreptidine 2-methylamino-2-deoxy-(3-L-glucopyrano' 
side (LXXIII).
r
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The mechanism of formation of glycosides by the
Koenigs-Knorr reaction is based on the general theory of
301
displacement reactions as suggested by Frush and Isbell 
According to this mechanism, the ion or molecule replacing 
the halogen must approach the carbon atom from the opposite 
side to that occupied by the halogen in the presence of 
excess of silver carbonate or silver oxide.
Br
OAc
(LVI)
CH20Ac
Br*"
AcC^ .OAc
OAc
(LXXIV)
CH2 0Ac
AcO X?Ac
OAcR = aglycon
(LXXV)
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This substitution follows first order kinetics 
accompanied by a Walden inversion yielding the acetylgly- 
coside (LXXV) of configuration opposite to that of the 
parent halide. The ionization of halide to form a cation
3 02)303
(LXXIV) is considered to be the rate controlling step
The cation in turn combines with the hydroxyl group of the
aglycon as rapidly as it is formed.
The substitution of halogen at C(i) of the 0,-acetyl-
glycosyl halide is influenced by neighbouring groups i.e.
304 aol
at C(s)« According to Pacsu , and Frush and Isbell , 
in 0.-acetylglycosyl halides having the halogen at C(i) trans 
to the acetoxy group at C(3 ) (tetra-£-acetyl-a-D~manno- 
pyranosyl bromide (LXXVIJ), the 0_-acetyl group may attack 
the back face of as the halogen recedes, thus forming
an orthoester carbonium ion (LXXVII). Under slightly 
basic conditions, the alkoxy radical then attacks this 
carbonium ion to form the stable orthoester (LXXVTII).
CH3
I
CHgOAc CHgOACCHgOAc
C-OCBg
AcO
(LXXVI) (LXXVII) (LXXVIII)
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Besides the alkyl orthoacetate (LXXVIII), a small amount 
of alkyl (3-D-glucopyranoside may be formed from the trans- 
isomer without participation of the 2-0,-acetyl group.
In an O-acetylglycosyl halide'having the halogen cis 
to the neighbouring acetyl group, for instance, acetobromo- 
glucose (LVI), steric conditions make reaction between 
and the neighbouring acetyl group impossible and no 
orthoester is formed. The halogen is, therefore, replaced 
readily by nucleophilic group from the environment 
accompanied by Walden inversion.
The Koenigs-Knorr reaction is normally carried out 
in a solvent which will dissolve the acetylglycosyl halide 
and the substance carrying the free hydroxyl group. The 
solvents most commonly used are chloroform, benzene, carbon 
tetrachloride, ether, dioxane and xylene. During the 
present work, difficulty was experienced in the choice of 
the proper solvent. None of the above-mentioned solvents 
gave any glycoside and the starting material was recovered in 
each case. This may be attributed to the insolubility of 
hepta-acetylstreptidine in these solvents. Consequently, 
NN-dimethyl-formamide was selected and found to be a good 
solvent for the reactants as well as for the final product 
and also inert under the experimental conditions.
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The yield of glycoside is affected not only by 
the nature of the solvent but also by the type of condensing 
agent, its amount and the time of contact. Helferich
305
and Wedemeyer prepared a number of glycosides by using 
the more readily available catalysts or condensing agents 
such as zinc oxide, cadmium oxide, mercuric oxide, zinc 
acetate, mercuric cyanide and mercuric bromide under various 
conditions. They suggested that the most effective catalyst 
was mercuric cyanide which yielded (3-glycoside, though 
certain other mercuric salts such as mercuric acetate have
306
been reported to give a-glycosides also. During the
wD/’A-
presen^, however, attempts to prepare the glucoside using
mercuric cyanide were unsuccessful.
300
Although Koenigs and Knorr and Ness, Fletcher and 
307
Hudson have carried out the reaction for the preparation
of simple glycosides without the use of condensing agent,
these cases are exceptions to the general rule. Normally,
a catalyst or condensing agent is required to act as an
acid acceptor and accordingly silver carbonate and silver
300
nitrate were first used by Koenigs and Knorr . Silver 
carbonate and silver oxide are still extensively used in
308
the synthesis of (3-glycosides. Pyridine alone is 
unsuitable since it reacts with acetobromoglucose yielding 
tetra-O-acetyl-glucopyranosyl pyridinium bromide. Using
92
quinoline as the condensing agent, however, Helferich and
309
Bredereek isolated a small yield of a~glycoside•
Likewise, it was observed that when hepta-acetylstreptidine
dihydrobromide was treated with acetobromoglucose in the
presence of quinoline alone, a partially deacetylated product,
tetra-0.-acetylstreptidine a-D-glucoside was obtained, the
a-configuration being given on the basis of optical rotation*
Since the yield was very small, this procedure was not
employed for the preparation of other glycosides.
Later on, using silver oxide and quinoline together 
310
as condensing agents , streptidine (3-glucoside was prepared
in very small yield. This low yield could be attributed to
the presence of the byproduct, water, itself a hydroxylic
311
compound, in the reaction mixture. This may, then, react 
preferentially with the O-acetylglycosyl halide to give a 
third hydroxy compound (tetra-O-acetyl-D-glucopyranose ) which 
will then react with more of the halide.
The amount of the product lost in these side reactions 
can be cut down by decreasing the active water content of the 
reaction to a minimum with various internal desiccants such
312 313
as anhydrous sodium sulphate , calcium chloride, anhydrous
314
magnesium perchlorate, and finely divided calcium sulphate
315
hemihydrate (Drierite ) . The properties of drierite such
as inertness to nearly all materials except water and
93
insolubility in all the common solvents, make it an ideal 
internal desiccant for use at normal or moderately
elevated temperatures. Though the yields of glycosides
3 1 5
were improved in many instances , it did not give
encouraging results in the present study since the reaction
311
with water could not be entirely eliminated ; secondly,
316
the velocity of condensation was possibily diminished.
The use of an entraining agent has, also, been suggested
317
for the removal of water from the reaction mixture , the 
reaction being conducted at elevated temperature or under 
vacuum. After a series of experiments, it was found 
that the water formed during the reaction could best be 
removed by carrying out the reaction under high vacuum.
This method has, also, proved useful in the preparation 
of the remaining glycosides.
Deacetylation of AcetylstrePtidine 6 -Glycosides.
Deacetylation of acetylstreptidine (3-glycosides was
2 6 2 ) 2 7 2
carried out in dry methanol at 0 ° saturated with dry ammonia 
as explained earlier (page 69 ) for dodeca-acetyldihydrostre-
ptomycin and undeca-acetylstreptomycin. Undeca-acetylstreptidine 
P-D-glucopyranoside (LVII), deca-acetylstreptidine 2-amino-2- 
-deoxy-p-D-glucopyranoside (LX), deca-acetylstreptidine 
2-methylamino-2-deoxy-p-D-glucopyranoside (LXXII) and 
deca-acetylstreptidine 2-methylamino-2-d6 0xy-(3-L-glucopyranoside 
(LXXIII) were deacetylated in this way to streptidine (3-D-
94
-glucopyranoside (LVIII), streptidine 2-amino-2-deoxy-(3-D- 
-glticopyranoside (LXI), streptidine 2-methylamino-2-deoxy-(3- 
-D-glucopyranoside (LXXIX) and streptidine 2-methylamino-2- 
-deoxy-(3-L-glucopyranoside (LXXX). These bases were 
purified by conversion to the hydrochloride or sulphate and 
further characterised by preparing the respective picrate 
or helianthate.
NH
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HO
OH
HO
HO
( LXXIX )
HO
OH
OH NHh2n.^.nh
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Synthesis of Str.eptidine-oxyethyl 6-D-Glucopyranoside.
The preparation of streptidine oxyethyl (3-D-glucopyranoside 
was undertaken as a model compound for the preparation of 
streptidine-oxyethyl 2-N-methylamino-2-deoxy-(3-D-glucopyranoside 
(LXXXI) which hears a structural analogy to the streptomycin 
molecule (XXIa) as shown below. Two basic units of streptomycin
NH
HaN.C.NH NH
H 3C
HN.C.NH*
D
NH t w t  \ I! (XXIa)
OH
CHjjOH
CH3NH
( LXXXI )
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molecule i.e. streptidine aid N-methyl-glucosamine fragments 
could, therefore, he separated by an ethoxy group which 
apart from the extra-cyclic carbonyl group essentially 
represents the streptose fragment as far as the linkages of the 
two basic fragments are concerned. Thus streptidine 
oxyethyl 2-N-methylamino-2-deoxy-p-D-glucopyranoside may possess 
the characteristic shape of the streptomycin molecule essential 
for the biological activity of the antibiotic.
For the preparation of streptidine-oxyethyl (3-D-gluco­
pyranoside, streptidine and glucose fragments of streptidine 
(3-D-glucoside (LVIII) were required to be separated by an 
ethoxy group (-0-CH2-CH2- ). This could be achieved either 
by linking the p-hydroxy-ethyl group (H0-CH2-CH2- ) to the free 
hydroxyl group of hepta-acetylstreptidine dihydrobromide (LV) 
or by replacing the halogen of acetobromoglucose at C(i) 
with p-hydroxy-ethoxy group (H0-CH2-CH2-0-) and thus 
condensing the two units. One approach to the former route
might lie through the reaction of ethylene oxide with '
318
hepta-acetylstreptidine under acidic conditions , but this 
would, undoubtedly, lead to the deacetylation of the latter.
The alternative route which seemed more feasible was, therefore, 
followed.
In a preliminary investigation, ethylene chlorhydrin 
and ethylene bromhydrin were condensed with acetobromoglucose 
to form tetra-O^acetyl-^-chloroethy]) p-D-glucopyranoside 3 1 9
97
(LXXXI I) and tetra-0.-acetyl-^-bromoethyl) p-D-g lac opyrano side
(LXXXIII) respectively. Neither of these substances gave
any condensed product in reaction with a model compound, 
cyclohexanol. This failure is attributed to the lower 
reactivity of the alkyl halide halogen compared with the 
halogen at the reducing carbon of ,0 -acetylglycosyl halides.
A search of the literature at this juncture revealed
32 U
that toxyloxy group could be replaced by methoxy and
321
benzylphenoxy groups using sodium hydride and other 
condensing agents. The reactivity of tosyl esters has been
322
studies in detail by Tipson and found to be in the orders 
ethanol)> p-ethoxyethanol^> cyclohexanol. This is further
supported by the observation of Wiggins and Wood that in 
general a tosyl group attached to a primary hydroxyl group
Cl Br
/
CHgOAc CH2
ch2 CH*
CHjjOAc CHa
OAc
OAc
(LXXXII) ( LXXXIII)
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reacts more readily than when attached to a secondary hydroxyl 
group. It is evident, therefore, that the tosyl ester of 
tetra-0.-acetyl-(2-hydroxyethyl) (3-D-glucopyranoside (XXXXIV) 
will be more reactive than the corresponding ester of 
hepta-acetylstreptidine.
For the preparation of the tosyl ester, acetobromoglucose 
(LVI) was condensed with ethylene glycol by the procedure of
3 2 4 uFischer and Fischer to yield tetra-0.-acetyl-^-hydroxy-
ethy]) (3-D-glucopyranoside (LXXXIV-). This was further
treated with dry p-toluenesulphonyl chloride in dry
pyridine, the latter serving both as solvent and also to
neutralize the hydrochloric acid formed. After reaction
at 0 ° for two hours, the excess of j)-toluenesulphonyl chloride
was hydrolysed slowly with cold water and subsequently
removed along with other by-products by adding more cold
water. The product, tetra-0.-acetyl-^-tosyloxyethy]) (3-D-
-glucopyranoside (LXXXV), after purification was crystallised
18
from ether as colourless needles, m.p. 109-110'°, [a]D - 13.1°.
CHgOAc CH2 0Ac CH2 0Ac
CLXXXIV) (LXXXV)
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The reaction of the tosyl ester (LXXXV) with hepta- 
acetylstreptidine dihydrobromide in the presence of sodium
321
hydride seemed to be unworkable since alkaline conditions
would in all probability deacetylate the reactants, whilst
320
the reaction conditions used by Heyl, Herr and Centolella 
were found to be too mild to start the reaction.
However, it has been observed that during the 
preparation of sulphonic esters int he presence of pyridine,
326
a number of side reactions occur including ether formation 
(LXXXVI). Such reactions are favoured only under rather 
drastic or prolonged conditions. Likewise, intramolecular 
CH3 .C6H4 .S02 .0R + R f0H— > ROR 1 + CH3 .C6H4 S03H
(LXXXVI)
formation of a cyclic ether ("dehydration" ) has also 
been shown to occur when 1,2-0-isopropylidene-D-glucofuranose 
(LXXXVI I ) was treated with excess of ]>-toluene sulphonyl 
chloride in boiling pyridine-chloroform for eight hours.
The product isolated was 3,6-anhydro-l,2-0.-isopropylidene-5- 
-O-tosyl-D-glucose (LXXXVIII) instead of 3,5,6-tri-0.-tosyl
327 328
derivative which was obtained at 40°
HjjCOH
TsOCHHOCH
Ts = CH3 .C6H4 .S02- 
( LXOTIl) ( LXXXVIII )
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It seemed to be possible, therefore, that ether 
formation may be accomplished from the tosyl ester under 
such drastic and prolonged conditions* Consequently hepta- 
-acetylstreptidine dihydrobromide (LV) and tetra-0 -acetyl- 
-2-(tosyloxyethyl) (3-D-glucopyranoside (LXXXV) were allowed 
to react in NN-dimethylformamide in the presence of Drierite 
to ensure freedom from moisture, and silver oxide to remove 
the hydrogen bromide and to neutralize the liberated 
Jl-toluenesulphonic acid which is sufficiently acidic to
278
deacetylate the reaction products. After a series of 
experiments, the reaction was conducted at 95 c for eight 
hours with continuous stirring. The product undeca-acetyl- 
streptidine-oxyethyl (3-D-glucopyranoside (LXXXIX) was 
purified and deacetylated as for streptidine (3-D-glucopyranoside 
(LVIII). The deacetylated product, streptidine-oxyethyl (3-D- 
-glucoside (XC ) was confirmed by conversion to its crystalline 
dihelianthate.
The low yields of the intermediates in the preparation 
of streptidine-oxyethyl (3-D-glucopyranoside necessitated the 
repetition of the experiment many times to collect convenient 
quantities of the intermediates. Consequently, the preparation 
of streptidine-oxyethyl 2-methylamino-2-deoxy-(3-D-giucopyranoside 
was abandoned.
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Degradation of Dihydrostreptomycin Sulphate and Streptidine
2-amino-2-deoxy-0-D-glucopyranoside Sulphate.
As stated earlier (page 74 ) dihydrostreptomycin sulphate
was converted into strepturea and streptamine derivatives
by controlled hydrolysis with barium hydroxide solution in
order to ascertain the optimum conditions for the degradation
of streptidine 2-amino-2-deoxy-(3-D-glucopyranoside sulphate to
its corresponding strepturea and streptamine derivatives.
224.283
Like alkaline hydrolysis of streptidine ,
dihydrostreptomycin sulphate was degraded with 0.35N barium 
hydroxide under reflux for different periods. After one 
hour refluxing, two moles of ammonia per mole of dihydrostre­
ptomycin were liberated and the excess of barium hydroxide 
was precipitated as barium carbonate with solid carbon dioxide. 
The neutral pale yellow filtrate after decolourisation with 
charcoal, afforded a micro-crystalline strepturea (3-L-dihydro-
19
streptobiosaminide (XXVII), [ci]^  - 90"(in water).
Treatment with charcoal also facilitated the removal of traces
of undecomposed dihydrostreptomycin. The strepturea derivative
was characterised by acetylation using the two stage procedure
222
of Wolfrom and his coworkers , crystalline deca-acetylstrepturea 
(3-L-dihydrostreptobiosaminide (XCIa) being obtained.
Degradation of dihydrostreptomycin sulphate with 0.35N
103
barium hydroxide under reflux for twenty four hours in the 
same way afforded streptamine (3-L-dihydrostreptobiosaminide 
(XXVIII). The latter showed the presence of primary
3 2 9
amino groups with ninhydrin solution and the absence of 
guanidine or urea groups was demonstrated with alkaline
330
solution of potassium ferricyanide and sodium nitroprusside 
The crude product was purified by adsorption on charcoal and 
subsequent elution with methanol acidified with hydrochloric
17
acid, yielding the hydrochloride, m.p. 194-196" and [a]D - 8 8 . 6  
(in water). Its identity was confirmed by acetylation 
following a procedure similar to that used for deca-acetyl- 
strepturea (3-L-dihydrostreptobiosaminide. The crystalline 
product, deca-acetylstreptamine (3-L-dihydrostreptobiosaminide 
(XCIb) showed m.p. and optical rotation comparable to a
233
similar product cited by Wolfrom and Polglase
R
CHjjOAc
00
I
(a) R = -NH.C.NHAc
(b) R = -NHAc
OAc
( XCI)
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Streptidine 2-amino-2-deoxy-(3~D-glucopyranoside sulphate 
was degraded similarly by stepwise hydrolysis with 0.35N 
barium hydroxide to strepturea 2-amino-2-deoxy-(3-D-gluco­
pyranoside (XCII) and streptamine 2-amino-2-deoxy-(3-D-gluco- 
pyranoside (XCIII ).
(Streptidine 2-amino-2-deoxy-(3-D-glucopyranoside.)
(LXI)
ch2oh
nh2 nh2
(XCII) (XCIIIj
Attempted Anomerization of Dodeca-acetyl-dihydrostreptomvcin.
The relationship of biological activity and stereoisomerism 
of some antibiotics has been studied in the past. The
3 31
stereoisomer of penicillin synthesised from L-penicillamine 
was found to be devoid of antibacterial activity. Of the four
105
3 3 2
possible stereoisomers of chloramphenicol , only the 
natural antibiotic, the D(-) threo-isomer inhibits bacterial 
growth and protein synthesis while its )er.ythro-stereoisomer
33 3
is only a very weak growth inhibitor • Similarly in the
255
case of cycloserine, the natural D-isomer is more active
3 34
than the synthetic L-isomer • Thus the change in
configuration affords a means of studying the importance of
molecular shape of the antibiotic. The anomerization of
glycosidic linkages in dihydrostreptomycin would alter the
whole shape of the molecule without effecting the nature of
the constituent units, thus, producing new isomers.
Dihydrostreptomycin has been shown to possess an
a-linkage between N-methy1-glucosamine and dihydrostreptose^and
222
a (3-linkage between dihydrostreptose and streptidine units •
The former linkage is comparatively much more stable in acidic
solutions than the latter, drastic acidic conditions being
226
necessary to cleave the a-linkage « In order to accomplish 
the conversion of the (3-linkage in dihydrostreptomycin to a 
more stable a-linkage, anomerization of dodeca-acetyl-dihydro- 
streptomycin was attempted in non-aqueous media with acidic
335 336
catalysts such as boron trifluoride , stannic chloride
336
titanium tetrachloride and a mixture of sulphuric acid
3 37
and acetic anhydride by the usual procedures. In each case 
the final product was found to be either the starting material,
106
the hydrolysed product or an unidentified decomposed
33 8
substance. Anomerization with sodium hydroxide , an 
alkaline catalyst in a mixture of dry dioxane and dry ether 
resulted in partial deacetylation of dodeca-acetyldihydro- 
streptomycin to a product which oh re-acetylation with acetic 
anhydride in pyridine afforded the starting material.
The inability to anomerize the (3-linkage in dodeca- 
-acetyldihydrostreptomycin to the a-form seems to conform 
with the mechanism of anomerization which is thought to 
involve participation of the neighbouring acetoxy group, since 
this is absent in the dihydrostreptose moiety. This mechanism 
has been investigated by Lemieux and his coworkers.
295,339
Lemieux and Brice have anomerized penta-£.-acetyl
(3-D-glucopyranose (LXIV) in chloroform solution by introducing 
1 4C-labelled acetate ion into the reaction mixture.
Since the C (1 )-to-acetoxy group bond of (3-D-glucopyranose
295
penta acetate is highly labile , the most favourable route 
for exchange of acetate ion is by dissociation of the 
C(t)-to-acetoxy group bond. The starting material was, 
therefore, found to equiliberate very rapidly with the 
labelled acetate ions (XCIV) formed by the participitation 
of C(2)-acetoxy group. The formation of this 1,2-a-cyclic ion 
(XCIV) is followed by a slower reaction to form a second 
intermediate such as 1 ,6 -orthoester ion (XCV) or a carbonium ion 
(XCVI) which was assumed to be the rate-controlling stage for the
107
p—>a conversion. This new intermediate particularly (XCV)
combines with the labelled acetate ion to form labelled penta-0.- 
-acetyl a-D-glucopyranose (XGVII). During these transformation; 
which are reversible reactions, the formation of highly 
complex and labile substrate molecules, inevitably leads 
to a number of side reactions and it is difficult to obtain 
a true equilibrium.
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340
Lind "berg , on the other hand, anomerized a 
mixture of tetra-0.-acetyl-isopropyl (3-D-glucopyranoside and 
hepta-0.-acetyl-ethyl (3-cellobioside using titanium 
tetrachloride as the catalyst and obtained a-anomers in 6 6 and 
75 per cent yield. On the basis of this study, he deduced 
that the glycosidic linkage is not completely broken down.
341,342
Lemieux and his collaborators , however, have
recently postulated that tetra-O-acetyl-methyl (3-D-glucopyranoside
(XCVHI) is transformed to an ortho-ester (XCIX) under the
influence of the acid catalyst, The participation of
c (2 )-acetoxy group weakens the C(A )-to-methoxyl group bond and
the transition state (XCIX) readily leads to the ion-pair
A
CHgOAc
OCH
OAc
AcO
0-
OAc
AcO
CHa CH3
(XCVIII)
CHgOAc
OAc
AcO
OAc
(XCIX)
O',
>AcAcO
0-C
( Cl ) t c ) CH:
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intermediate (£.)• The collapse of the ion-pair then 
results in the formation of tetra-0.-acetyl-methyl a-D-gluco- 
pyranoside (Cl).
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Melting points are uncorrected. Ultraviolet 
absorption spectra were determined on a Hilger Uvispek 
photoelectric spectrophotometer (Model H.700.303) fitted 
with fused silica prism.
A
Materials
Dihydrostreptomycin sulphate and streptomycin sulphate 
used in the present investigation was the medicinal grade 
supplied by Glaxo Laboratories Ltd.
Reagents
Silver oxide was freshly prepared from silver nitrate 
and potassium hydroxide, washed thoroughly with water and 
acetone, and dried over phosphorus pentoxide.
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" Drierite f! , finely divided calcium sulphate 
hemihydrate was dried by heating for two hours at 230-2500 
before use.
NN-dimethylformamide was kept over n Drierite n for 
twenty four hours and distilled before use. Pyridine and 
quinoline were refluxed over potassium hydroxide and then 
distilled. Chloroform was washed repeatedly with water, 
dried over calcium chloride and distilled before use.
Ill
Dihydrostreptomycin
Dihydrostreptomycin sulphate (5.94 g.) was dissolved
in water (60 ml.) and the solution passed through a
column (25 x 1.8 cm.) of anion exchange resin (De-Acidite
P.P.). The column was washed with water (ca. 50 ml.).
The combined eluates were freeze-dried giving the
sulphate-free white amorphous base (4.05 g., 85$) t
2 0
m.p. 193-195° (decomp, micro block) [ a - 94° (c 1.06“ ? l)
in water) •
Dodeca—acetyldihydrostreptomycin
(a) (Based on the method of Wolfrom, Cron, De Walt and 
2 2 2
Husband )•
Dihydrostreptomycin (9.41 g.) was stirred in dry 
methanol (250 ml.) and pyridine (60 ml.). Acetic anhydride 
(100 ml.) was added in 5 ml. portions with vigorous 
stirring over a period of 45 minutes. The solution was 
maintained for one hour at room temperature and then 
concentrated below 50° in vacuo. The viscous residue
(ca. 1 0  ml.) was treated with dry ether to give a white 
precipitate which was washed twice with dry ether.
The hygroscopic precipitate was stirred with pyridine 
( 1 0 0  ml.) and acetic anhydride ( 1 0 0 ml.), the latter 
being added in small amounts. The resultant solution
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was kept at room temperature for forty four hours, and
then heated at 50° for five hours. After cooling,
the solution was poured onto crushed ice (1500 g.)
with stirring. The aqueous solution was extracted
with chloroform (5 x 80 ml.) and the chloroform extract
evaporated to a small volume (ca. 15 ml.) in vacuo
below 50°. The syrupy mass on trituration with crushed
ice (150 g.) yielded a cream coloured solid (ca. 15 g.).
Extraction of the aqueous solution with chloroform
afforded some more solid (ca. 3 g.). The combined
product was dissolved in chloroform ( 1 0 0  ml.), the
solution dried (CaCl2) and evaporated to a semi-solid
residue which was redissolved in benzene ( 1 0 0 ml.).
The benzene solution was filtered and added slowly to
light petroleum (b.p. 80-100°) (1500 ml.). The product
reprecipitated from benzene and light petroleum (b.p.
80-100°) and dried in a vacuum desiccator gave dodeca-
—acetyldihydrostreptomycin (14.1 g., 80.2$), m.p. 152—155°
(decomp.) sintered at 130°, [cx] — 67.6° (c 1.086 in
2 2 2
chloroform). Wolfrom et al give m.p. 153-155°,
r t20
[oc]D - 67°.
Ponnd: C* 48.0; E, 5.9; E, 8.5,
Calculated for 0 4 5 2^ 5 0 2 4 ^7 .2H2 09 C, 48.1; s H, 6.2; E, 8.7$
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(b) Dihydrostreptomycin sulphate (10.25 g.) was stirred 
in dry methanol ( 2 0 0  ml.) and pyridine (60 ml.).
Acetic anhydride (100 ml.) was added in 5 ml. amounts 
with constant stirring over a period of fifty minutes.
Fused sodium acetate (10.47 g.) was incorporated and 
stirring continued for a further twenty four hours.
Sodium sulphate was removed and the filtrate concentrated 
in vacuo below 50° to a semi-solid mass which was 
triturated and washed with ether. The solid mass after 
drying was further treated with acetic anhydride and 
pyridine and worked up as in method (a) (yield 11.4 g.,
75$), m.p. 152-155° (decomp.) sintered at 130°.
Unde ca-ace tvlstreet omvc in
Streptomycin sulphate (5.1 g.) was acetylated as 
in method (b) for dihydrostreptomycin sulphate yielding 
unde ca-acetvlstrent omvc in (5.3 g., 71$), m.p. 168-170° 
(decomp.) with sintering at 145°, [a] ^ 1 - 64.5°
(c 1 . 1  in chloroform).
Founds C , 47.9; H, 5.6$ If, 9.0,
C4 3 H6 1 0 2 3 ir7 .2H2 0 requires C, 47.8; E, 6.1; F, 9.1$.
Uhdeca-acetvldihydrostrentomycin
A solution of undeca-acetylstreptomycin (1.05 g.) 
in glacial acetic acid was shaken in an atmosphere of
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hydrogen with platinum oxide2 2 8 (0*157 g.) at room 
temperature and atmospheric pressure* The platinum 
oxide was hydrogenated prior to the addition of 
undeca-acetylstreptomycin. After eighteen hours,
2 0 ml. of hydrogen had been taken up ( 1 mole).
The decanted solution was filtered through a sintered-glass
funnel and the acetic acid removed in vacuo below 50°
leaving a viscous residue which on trituration with
dry ether afforded a white solid (0*95 g.)* This was 
washed thoroughly with dry ether and dried in a vacuum 
desiccator over potassium hydroxide, to yield undeca—
—ac e tv1dihvdro s trep tomvc in. m.p* 156—158° (decomp.)
r *12 1 ,
with sintering at 130-135°, [ajp - 58*4° (c 1.1 m  
chloroform).
Pound: C, 47.1; H, 6*7; F, 9.5,
C4 3 H6 3 0 2 3 H7 *2E 3 0 requires C, 47*7; H, 6*2; IT, 9.05$
Uhdeca-acetyldihydrostreptomycin did not reduce 
Pehling’s solution on boiling.
Acetvlation of Undeca-acetyldihydrostreptomycin_to 
Dodeca—acetvldihydrostreptomycin
U n d e c a — acetyldihydrostreptomycin ( 0 . 2 5  g . )  was 
acetylated in pyridine ( 1 0 ml.) with acetic anhydride 
( 1 0 ml.) at room temperature for forty eight hours,
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followed by heating at 50° for four hours with stirring. 
The resultant solution was concentrated in vacuo below 
50° to a viscous residue which on trituration with dry 
ether afforded a white amorphous substance. After 
thorough washing with dry ether and drying in a vacuum 
desiccator, it was dissolved in chloroform ( 5 ml*) 
and added slowly to petroleum ether (b.p. 60-80°) (50 ml.) 
with stirring. The white amorphous precipitate was 
dried in a vacuum desiccator to give dodeca-acetyldihydro— 
streptomycin m.p. 152-155° (decomp.), [a]^ - 66.9°
(c 0.88 in chloroform). A sample dried at 100® for 
three hours in vacuo was analysed.
Pounds F, 9.2,
Calculated for C4 5 H65 02 4 F7 9 F, 9.00
Q-q—2-F—ac e tyl-F-me thylamino-2-de oxy-L-gluc opyrano syl- 
-(l-» 2)-fl.-ft-3~C-tritylox.ymeth.yl-5-deoxy—L—lyxofuranosido— 
-(W  4) -I.3-diguanidino-2 ,4,5,6-tetrahydroxycyclohexane.
(F—Acetyl tritvldihydr os treptomyc in)_.
Undeca-acetyldihydrostreptomycin (3.684 g.?0.0034 
mole) dried over phosphorus pentoxide was dissolved 
in dry pyridine (30 ml.) and trityl chloride (7.876 g, 
0.028 mole) added. The resultant solution was kept in
116
a dark place for eight days when the solution attained 
reddish brown colour. The pyridine was removed in vacuo 
at room temperature and the residue was extracted with 
ether. The ether-insoluble buff-coloured residue was 
dissolved in chloroform (50 ml.) and the solution was 
concentrated to ca. 20 ml. After keeping in the 
refrigerator for two hours, crystals of pyridinium
270
trityl chloride (2.33 g., m.p. 172-173°) were 
collected. The chloroform solution was added slowly 
to ten times its volume of dry ether and the precipitate 
washed with ether and dried in vacuo (yield 4.6 g.).
This amorphous product was dissolved in dry methanol 
(20 ml.) previously boiled and cooled. The solution 
was saturated with ammonia at 0 ° and was kept at room 
temperature for twenty four hours. The solvent was 
removed in vacuo at room temperature, and the residue 
washed with ether and chloroform. The chloroform-insoluble 
residue (3.71 g.) was dissolved in M-dimethylformamide 
(15 ml.). [The insoluble residue (0.24 g.) was 
identified to be ammonium chloride by qualitative tests].
The UF-dimethy 1 formamide solution was stirred into dry 
ether (150 ml.) and the precipitate thus obtained 
fractionated by chromatography, a slurry of the above
117
crude product in ethanol (25 ml.) being poured on to 
the top of a column (30 x 1.9 cm.) of neutral ethanol- 
-washed alumina (75 g.). The column was eluted as 
recorded in table 1 * by using mixtures of ethanol and 
methanol in various proportions. The eluates were 
collected in a continuous fraction collector in 50 ml. 
quantities. The optical density of each 50 ml. fraction 
was measured at 259 m}i. and the next solvent was 
used when the last fraction of the previous solvent 
showed zero optical density. The combined solutions 
in each case were concentrated in vacuo below 45°.
Table 1
Fraction Solvent Volume collected 
in ml.
Ft. of 
product 
in g.
-nlcm. ,E w  at 
±/0 2 5 9 0 9 1  
in methanol
1 Ethanol 1 0 0 0 - —
2 Ethanol-me thanol 
4:1 2 1 0 0
0.376 1 0 . 8
3 Ethanol-me thanol 
1 : 1
1250 0.35 6.62
4 Ethanol—me thanol 
1:4
1150 0.55 4.38
5 Methanol 800 0.15
COCO«CO
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Eluates obtained with a mixture of ethanol and 
methanol (4:1) showed the greatest optical density at 
259 m^u and gave E—acetyltrityldihydrostreotomycin, 
m.p. 179-181° (decomp.), [a]** - 69.3° (c 1.5 in water). 
Found: E, 11.25,
6 4 2 ^ 5 7 °i 3^7 requires E, 11.3$
(Consistent analysis could not be obtained for C and H).
Paper chromatography using toluene—p-sulphonic 
acid (2.5 per cent) in n-bu±anol saturated with water 
showed a single spot (Rf value 0.16) as compared 
to Rf value 0.34 for E-acetyldihydrostreptomycin when 
sprayed with potassium ferricyanide-sodium nitroprusside
3 30
solution.
E-acetvltritvldihydrostrentomycin Dipicrate
E-acetyltrityldihydrostreptomycin (73 mg.) was 
dissolved in water ( 1 ml.) and a saturated solution of 
picric acid (7 ml.) representing67 mg. of picric acid 
was added slowly. The solution rapidly became turbid 
and was kept in the refrigerator for two hours, yielding 
F-acetvltritvldi hydro streptomycin di-picrate (from aqueous 
methanol), m.p. 178-180° (decomp.).
Found: 13.3,
C5 4 H3 3 02 7 E1 3 .2H20 requires E, 13.3$
1
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0-a-2 -lT-acetyl-ir-methylamino-2 -deoxy-L-glucopyranosyl- 
-(1^ 2)-0-{3-3-C-hydroxymethyl-5-deoxy-L-lyxofuranosido- 
-(1~* 4) —1,-3-diguanidino-2,4,5,6 -tetrahydroxycyclohexane.
(N-acetyldihydrostreutomycin) .
Dodeca-acetyldihydrostreptomycin (1.01 g.) was 
dissolved in dry methanol ( 1 0 ml.) previously boiled 
and cooled. The solution was saturated with dry 
ammonia at 0 ° and was kept at room temperature for twenty 
four hours. Methanol and ammonia were evaporated 
off in vacuo at room temperature, and the residue washed 
with chloroform. Addition of the chloroform—insoluble 
residue in dry methanol (5 ml.) to dry ether (50 ml.) 
gave F-acetyldihvdrostreutomycin as a white precipitate 
(0.466 g., 82$), m.p. 190-192° (decomp., micro-block),
[a] * 0 - 91.6° (c 1 . 0 1  in water).
Founds C, 42.2$ H , 7 »1J N , 15 • 1,
C2 3 H4 3 01 3 H7 .1-|hs0 requires C, 42.4; H, 7.1; IT, 15.02$
IT-Acetyldihvdro streptomycin Jipicrate
H-acetyldihydrostreptomycin (37 mg.) was dissolved 
in water (0 . 5  ml.). A solution of picric acid (4 ml.) 
representing 40 mg. of picric acid was added slowly.
After two hours at 0° w-aoetvldihydrostreptomycin. dipicrate 
was obtained as yellow prisms (from aqueous methanol), 
yield 25 mg., m.p. 168—170° (decomp.).
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Found: C, 36.2; H, 4.2*, N, 16.7,
C3 5H4 9 0 2 7Ni3 .2H2 0 requires C, 37.5$ H, 4.8; N, 16.3#
<0-a-2-N-acetyl-N-methylamino-2-deoxy-L-glucopyranosyl-(L —» 2 ) 
-O.-p-3-C-formyl-5-deoxy-L-lyxofuranosido-(1— * 4 )-l,3-diguanidino 
-2,4,5,6 -tetrahydroxycyclohexane. (N-Acetylstreptomycin).
Undeca-acetylstreptomycin (0.82 g.) was deacetylated by
the procedure used for N-acetyldihydrostreptomycin.
N-acetylstrePtomycin was obtained as white amorphous precipitate
(0.40 g., 81.2#), m.p. 180-182® (decomp., micro-block),
20
[a] - 87.1® (c 1.67 in water).
Found: C, 42.3; H, 7.1; N, 15.6,
 ^2 3^4 1 0 1 3N7 .ljgHjjO requires C, 42.5; H, 6 .8 ; N, 15*1%
Hydrolysis of Dodeca-acetvldihydrostreptomycin to 1%3-Bis 
(diacetylguanidino )-4 -hydroxy-2 ,5,6-triacetoxycyclohexane 
Dihydrobromide. (Hepta-acetylstreptidine Dihydrobromide.).
Dodeca-acetyldihydrostreptomycin (2.053 g., 0.0019 mole) 
in absolute chloroform (30 ml. ), was cooled in ice and a 31
287 (a )
per cent solution of hydrogen bromide in glacial acetic
acid (1 . 3  ml., 0.0058 mole) was added with stirring.
The solution on keeping for twenty four hours in the 
refrigerator deposited a sticky residue. The chloroform was 
decanted off and the residue washed with absolute chloroform 
(2 x 10 ml. ). The decanted chloroform solution with more
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31 per cent solution of hydrogen bromide in glacial 
acetic acid (0*4 ml., 0.0019 mole), yielded an additional 
amount of similar residue during the next twenty four hours.
The residue in each case was washed with dry ether 
(15 ml. ). The traces of acid were removed by adding chloroform 
(10 ml. ) and evaporating it in vacuo. This process was 
repeated a second time. The dry yellowish residues (1.068 g. ) 
were combined, dissolved in methanol (10 ml. ), treated with 
charcoal (0 . 2  g. ) and the colourless solution added with 
stirring to dry ether ( 1 0 0 ml.). The white micro-crystalline 
precipitate was collected on a sintered-glass funnel, and 
washed with dry ether, absolute chloroform (2 x 1 0 ml. ) and 
finally with dry ether to yield hepta-acetylstrePtidine 
dihydrobromide (0.728 g., 54 per cent) which did not 
crystallise from common organic solvents but had m.p. 180-183°
19 o
(decomp.), [a]^ - 5.4 (c 0.918 in methanol).
Found: C, 35.65 H, 4.7; N, 11.4;
(3 7 8
Br, 2 2 .0 ; acetyl, 41,
^ 2 2H3 g0 n N 5 • 2HBr.HgO requires C, 35.9; H, 4.9; N, 11.4;
Br, 2 2 .2 ; acetyl, 40.9$
The product was insoluble in absolute chloroform, ether 
&ncl petroleum ether but soluble in ethanol, methanol and 
NN-dimethylformamide•
122
The dlhy.tepteOTiflia. (m.p. 180-133°) (decomp.) was also 
obtained from undeca-acetylstreptomycin by the same method.
Found-. N, 11.25,
Cs2H3 2 O1 1N5 .2HBr.H2O requires N, 11.4$
l_^~Bis (diacetylguanidino )-4-hvdroxy-2.5 .6-triacetoxy- 
XHepta-acetylstrePtidine ).
Hepta-acetylstreptidine dihydrobromide (0 . 2 g. ) din 
methanol (3 ml. ) was treated with silver oxide (0.19 g. ) and 
the filtrate added to dry ether (50 ml.). The white precipitate, 
thus, obtained was dried in vacuo to yield hepta-acatvlst-raptldlnj 
m.p. 195-197° (decomp., micro-block).
Founds N, 14.9,
C2 2H3 2 O1 1N5 requires N, 15.1$
The product was soluble in methanol, ethanol and
NN-dimethylformamide but insolbule in absolute chloroform.
Q,c:ta-ac e t y 1 s t r e pt id ine.
Hepta-acetylstreptidine dihydrobromide (0.41 g. )
was acetylated in pyridine (5 ml. ) with acetic anhydride at
room temperature for twenty four hours, followed by heating
at S0° for one hour. The solution was evaporated in vacuo
to a viscous residue and the product triturated and washed
with dry ether to yield octa-acetylstreptidine (from chloroform-
224
ether) (0.232 g. ), m.p. 260-282° (micro-block). Peck e^ al
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give m.p. 260-262° (micro-block).
Found: N, 13.8, j
Calculated for C24H340i2N6 N, 14.04$ j
Penta-0.-acetyl-p-D-glucopyranose was prepared from D-glucose 
by tbe method given by Vogel287 m.p. 130-132°, [a]D + 3.6 
(c 1.1 in chloroform)*
2,3,4,6-Tetra-0.-acetyl-a-D-glucopyranosyl Bromide, 
(acetobromoglucose ) was prepared by the procedure of Jeremias,
Lucas and Mackenzie , yield 85$, m.p. 87-88°, [a]^ + 198°
2 8 9
(c 1.03 in chloroform). Jeremias .&£. &X give m.p. 88-39°.
The product underwent decomposition on storage at 
room temperature. It was, therefore, kept under petroleum 
ether (b.p. 40-60°) and was recrystallised from carbon 
tetrachloride-petroleum ether (b.p. 40-60 p) before use.
Tetra-acetyl-[4-0.-a-(l,3-diguanidino-2,5,6-trihydroxycyclohexyl) 
D-glucopyranoside], (Tetra-acetvlstreptidine a-D-glucopyranos_ide ) 
Hepta-acetylstreptidine dihydrobromide ^0.453 g., 0.00063 
mole) and acetobromoglucose (0.264 g., 0.00064 mole) were 
dissolved in dry quinoline (1.841 g.)• After keeping at 5° 
for eighteen hours, the excess of quinoline was washed off 
with dry ether by trituration. The ether-insoluble residue 
was shaken with silver oxide in chloroform (10 ml. ) and
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filtered. The filtrate on evaporation gave a residue 
which was washed with ether and extracted with absolute 
chloroform (5 x 10 ml. ). The chloroform extract on 
evaporation in vacuo gave an amorphous product (0.056 g. ) 
which was purified by precipitation from chloroform-ether 
and then from acetone-petroleum ether (b.p. 40-60°),
(yield, 0.037 g., 10%), It did not crystallise from 
common organic solvents. It was soluble in chloroform, ethanol, 
methanol and M-dimethylformamide but insoluble in ether 
and petroleum ether, m.p. 140-142° (decomp., micro-block),
19
M d + 15.6° (c 0.74 in chloroform).
Found: C, 41.9} H, 5.55; N, 13.1,
C2 2H3 5 0 i3N6• 2Hg0 requires C, 42.0; H, 6.4; N, 13.4%
a-Configuration for this product was assigned on 
the basis of optical rotation.
4-CH3-[ 1,3-bis(diacetylguanidino )-2,5,6-triacetoxycyclohexyl] 
tetra-0,-acetyl-D-glucopyran oside. (Undeca-acetylstreptidine 
(3-D-glucopyranoside ).
Hepta-acetylstreptidine dihydrobromide (0.67 g., 0.00093 
mole ) was dissolved in NN—dimethyIformamide (10 ml. ) in a 
flask wrapped in a black paper. The solution was kept 
in vacuo (0.2 mm. ) for fifteen minutes with constant stirring. 
Acetobromoglucose (0.378 g. 0.00092 mole) was added.
The solution was again maintained in vacuo, for ten minutes.
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Silver oxide (0®604 g.) and quinoline (4 drops ) were 
added simultaneously* The water liberated during the 
reaction was removed under vacuum (0*2 mm.). NN-dimethyl- 
formamide was added when necessary during the reaction 
period (8 hours) to maintain the volume.
After the reaction the solvent was distilled off 
in vacuo at room temperature. The viscous residue was 
triturated and washed with dry ether (5 x 10 ml. ) and 
extracted with absolute chloroform (10 x 10 ml. ).
The chloroform solution was kept in the refrigerator overnight 
and hydrogen sulphide passed into the cold solution.
The filtrate was evaporated and the tan-coloured residue 
precipitated from c hloroform-ether. The precipitate was 
redissolved in acetone and the solution decolourised 
with charcoal (0.150 g.). The filtrate when poured slowly 
into petroleum ether (40-60°) afforded undeea-acetylstreptidine 
6-D-.gliiftopv-ranns-t.dfi as a micro-crystalline precipitate which 
was dried ip, vacuo (yield 0.184 g. 9 22% )9 m.p. 164-167° (decomp. )
r -,18 \LQlJd - 25.5° (c 2.56 in chloroform).
Found: C, 46.25 H , 6.3$ N, 9.5,
CssH5o02oN6-2H20 requires C, 46.9$ H, 5.9$ N, 9.1#
A t t e m p t s  n n n r ta n g a t ln n  of H ecta-acetylstreEtlfljne_ filtodrobrpmide 
and acetobromoglucose.
(a) (Using quinoline as a condensing agent in the presence
^ tn sis .
of Drierite ).
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Hepta-acetylstreptidine dihydrobromide (0 . 4 5 7  g.,
0.00063 mole) was dissolved in NN-dimethylformamide (5 ml. ) 
in a flask protected from light. The solution was stirred 
with Drierite (1.08 g.) for thirty minutes. Silver oxide 
(0.516 g. ) and quinoline (2 drops) were added simultaneously 
and stirring continued for ten minutes. Acetobromoglucose 
(0*284 g., 0.00069 mole) was added and the mixture was 
stirred for eight hours at room temperature. After the 
reaction, most of NN-dimethylformamide was distilled off 
in vacuo (0.2 mm.) at room temperature. The residue 
was washed with ether (5 x 10 ml. ) and extracted with 
chloroform (5 x 10 ml. ). The chloroform extract on 
evaporation in vacuo gave 0.01 g. of tan-coloured residue 
{2% yield) (possibly an impure product). The methanol 
extract of the chloroform residue afforded 0.251 g. of
hepta-acetylstreptidine m.p. 193-196°.
305(b) (Using mercuric cyanide as condensing agent).
Hepta-acetylstreptidine dihydrobromide (0.14 g., 0.00019 
mole) and acetobromoglucose (0.082 g., 0.0002 mole) were 
dissolved in NN-dimethylformamide (10 ml. ). Mercuric cyanide 
(0.104 g. ) was added. Immediately the optical rotation was 
observed and it bacame constant (+1.64°— *+ 0.252°) after 
forty two hours. The reaction mixture was added to dry ether 
(30 ml. ) and kept in the refrigerator. A sticky residue was
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deposited which became amorphous on trituration with '
chloroform. It gave tests for Hg++, CN~ and Br". j
On purification from methanol-ether it afforded a residue 
(0.126 g.) still contaminated with traces of impurities.
Further purification with hydrogen sulphide yielded an 
amorphous substance which did not melt below 300 Further 
purification was without any success.
4-0.-(3-(l,3-diguanidino-2,5,6-trihydroxycyclohexyl) D-gluco- 
pyranoside. (Streptidine (3-D-glucopyranoside).
Undeca-acetylstreptidine (3-D-glucopyranoside (0.528 g. ) 
was dissolved in dry methanol (5 ml. ). The solution was
saturated with ammonia at 0° and kept for 15 hours at room
temperature. The solvent was removed in vacuo at room 
temperature and the residue washed with chloroform (3 x 20 ml. ). 
The chloroform—insoluble residue was redissolved in methanol 
(5 ml. ), filtered and the filtrate added slowly to dry 
ether (50 ml. ). The amorphous base could not be 
crystallised from common organic solvents and was dried 
in a vacuum desiccator to yield streptidine j3-D~iLlugopyr an osi de 
(0.178 g., 70$), m.p. 170-172° (decomp., micro-block)
30 , .
[<*]$ - 11.4° (c 0.615 in methanol).
Found: C, 3 7 .8 ; H, 7.0; N, 18.6,
CmHagOgNs.HaO requires C, 38.0; H, 6 .8 ; N, 19.0#
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Stj.eptjdjne P-D-glucopvranoside Djpicrate
Streptidine (3-D-glucopyranoside (64 mg. ) was dissolved 
in water (2 ml. ). A cold saturated solution of picric acid 
(6 ml. containing 70 mg. of picric acid) was added slowly 
and the turbid solution kept in the refrigerator for a few 
hours. Crystals were collected and washed with cold water 
(1 ml. ). Recrystallisation from aqueous methanol yielded 
.streptidine 6-D-glucopyranoside djpicrate, m.p. 260-262° 
(decomp., micro-block).
Found: C, 33.4$ H, 4.3$, . N, 18.4,
C26H34023Ni2.2H20 requires C, 34.0$ H, 4.2$ N, 18.3$
3,4,6-Tri-0.-acetyl-2-amino-2-deoxy-a-D-glucopyranosyl Bromide
Hydrobromide, (Acetobromoglucosamine Hydrobromide )f was
~ ~  - - ^ g Q  
prepared essentiallyythe methods of Irvine, McNicoll and Hynd ,
2 91
and Fodor and Otvos
Acetyl bromide (15.4 g., 0.127 mole) was stirred with 
D-glucosamine hydrochloride (6.2 g., 0.024 mole) for three 
days at room temperature. Excess of the reagent was 
removed vacuo. The dry residue was washed with ether
(25 ml. ) and than dissolved in warm chloroform (50 ml. )•
The filtered chloroform solution was concentrated to 35 ml., 
diluted with dry ether to turbidity and kept in the refrigerator* 
The crystalline product thus obtained was recrystallised from 
chloroform-ether (white needles) (yield 6.01 g., 55 per cent),
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m.p. 151-153° (decomp.) [a]^2+l48° (c 1.05 in acetone)
2 90
Irvine, McNicoll and Hynd give m.p. 149-150°,
[a]^2 -i- 148.4 (c 1.05 in acetone).
4-0-0-[l, 3-bis(diacetylguanidino)—2,5,6—tri-acetoxycyclohexyl] 
tri-0-aeetyl-2-amino-2-deoxy-D-glucopyranoside • 
(Deca-acetylstreptidine 2-amino-2-deoxy-0-D- 
-glucopyranoside).
Hepta-acetylstreptidine dihydrobromide (1.652 g.,
0.0023 mole) were dissolved in NN-dimethylformamide 
(15 ml.) in a flask protected from light. The solution 
was kept in vacuo (0 . 2 mm.) for fifteen minutes with 
constant stirring. Tri-0-acetyl-2-amino-2 -deoxy-a-D— 
glueopyranosyl bromide hydrobromide (1.06 g., 0.00236 
mole) was added and the solution was again evacuated 
as before. Silver oxide (3.018 g.) and dry quinoline 
(0.2 ml.) added simultaneously. The reaction was 
conducted as for the preparation of undeca-acetylstreptidine 
P—D—glueoside using proportionately larger quantities 
of solvents. The product (0.4 g. „ 20.6*) was crystallised
1 9
from methanol-ether} m.p. 132—134° (decomp.), [“Ip -12°
(c 0 . 8 8  in chloroform).
Pound: C, 46.3* H, 6.4} N, 11.3,
G3 4H4 9 01 8 N7 .2H20 requires C, 46.4} H, 6.1} 11.1*
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4 Or-p-*(11 5—diguanidino—2 , 5 * 6—trihydroxycyclohexyl) 
2-amino-2-deoxy-D-glucopyranoside Trihydrochloride.
(Streptidine 2-amno-2-deoxy-6—D-glucp-pyranoside Trihydro­
chloride) .
Deca-acetylstreptidine 2-amino-2-deoxy-(3-D- 
-glucopyranoside (1,145 g.) was dissolved in dry methanol 
(TO ml.). The solution was saturated at 0° with dry 
ammonia. After keeping at room temperature for eighteen 
hours, the solvent was evaporated off in vacuo.
The residue was extracted with chloroform (3 x 20 ml.) 
and the chloroform-insoluble residue was taken up in 
dry methanol (5 ml.). The filtered solution was 
slowly poured into dry ether (50 ml.) yielding an 
amorphous white precipitate (0.50 g., 87.3$).
A part of this precipitate (120 mg.) was 
dissolved in water (5 ml.) and was treated with charcoal 
(l g.) and centrifuged to separate the aqueous solution. 
The charcoal was washed twice with water and then with 
dry methanol. It was suspended in dry methanol (5 ml.) 
and acidified with IT methanolic hydrochloric acid.
After shaking for a few minutes, the methanolic solution 
was separated by centrifugation. The charcoal was 
washed twice with methanol (10 ml*) and the combined
131
methanolic solutions were filtered and concentrated 
in vacuo to csu 5 ml. The hygroscopic product (80 mg.) 
was obtained by precipitation in dry ether (75 ml.), 
m.p. 160—162° (decomp.), [a]^9 - 17.6° (c 1.02 in water)• 
A sample for analysis was dried at 80* for three 
hours in vacuo.
Founds C, 32.0; E, 5.8; E, 17.8,
ci4S29 08^7 *3HC1 requires C, 31.6;, H, 6.05; E, 18.4$
Streptidine 2-amino—2-deoxy—(3-D-glucopyranoside sulphate.
The crude base (80 mg.) obtained in the previous 
experiment was dissolved in dry methanol (5 ml.) and 
the solution cooled and acidified with E sulphuric acid 
to pE 3. After fifteen minutes the suspension was 
centrifuged and washed with dry methanol and dry ether, 
and the product dried in a vacuum desiccator to yield 
streptidine 6-D-glucosaminide sulphate (70 mg.),
go r
[ocj-p - 17.r  (c 1.07 in water). For analysis the 
sample was dried at 80° for three hours.
Found: E, 17.2,
Ci4^9 08E7 .1^ H2S04 requires E, 17.2$
Streptidine 2—g>m'in o—•2—deoxy—3-D—glue op y.ranoside—Tri— 
helianthate.
The crude base (120 mg., 0.00028 mole) obtained in
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the preparation of streptidine 2-amino-2-deoxy-|3-.;D- 
-glueopyranoside trihydrochloride was dissolved in 
water (2 ml*), the solution acidified with IT/10 
hydrochloric acid and methyl orange (301 mg., 0.0003 mole) 
dissolved in 26 ml. of 50 per cent aqueous methanol at 
60% added slowly. The flocculent precipitate was 
redissolved at 50° with the addition of 10 ml. of 50 per 
cent aqueous methanol. After setting aside at room 
temperature overnight needle-like crystals of streptidine 
P—D-glucosaminide trihelianthate were deposited.
These were separated and washed with 50 per cent aqueous 
methanol ( 2 ml.) and dried (yield 96 mg.), m.p. 236-239° 
(decomp.).
C, 48.0; H, 5.9} F, 16.0} S, 6.7, 
C5 6 H7 7 0 1 7 FlffSs .2H20 requires 0, 48.75} H, 5.6} F, 16.3} S, 7.#
2~F-Methvlainino~2~deoxy~a-I)-glucopyranose Hydrochloride
was prepared by the method of Kuehl, Flynn, Holly,
2 2 6
Mozingo and Folkers.
5 >4,6 -Tri-O-ac e tyl-2-F-methylamino-2-deoxy-q-D- 
-glucopyranosyl Bromide Hydrobromide.
Acetyl bromide (6.15 g., 0.05 mole) was stirred 
with 2-F-methylamino-2-deoxy-a—D-glucopyranose 
hydrochloride (3.1 g., 0.00135 mole) for two days at room
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temperature. Excess of the reagent was removed in vacuo 
and the residue was washed with dry ether (25 ml.).
The residue was, then, dissolved in chloroform (50 ml.) 
and filtered. The filtrate was concentrated to about 
1 0  ml. and poured into dry ether with stirring.
The precipitate after washing with dry ether, was dried 
in vacuo over phosphorus pentoxide. Attempts to 
crystallise this hygroscopic product from non-alcoholic 
solvents were without success, (yield 2 . 1 g., 3 3 .6$),
g 3
m.p. 120-122° (decomp.), [a]^ + 149.5° (c 1.25 in
acetone).
Pounds 0, 32.7; H, 4.7; tf, 3.1; Br, 32.9,
3 H2 o 07 NBr.HBr requires C, 32.4; H, 4.8; F, 2.9; Br, 33.2$
4-0-P—[ly3-bis(diacetylguanidino)-2,5,6-tri-acetoxycyclohexyl] 
tri-O-acetyl-2-H-methylamino—2-deoxy-D-glucopyranoside. 
(Beca-acetvlstreptidine 2-F-methvlamino-2-deoxv-g-D- 
-glucopyranoside).
Hepta-acetylstreptidine dihydrobromide (1.35 g.,
0.0018 mole) was dissolved in freshly distilled 
HF-dimethylformamide ( 1 0 ml.) in a flask protected from 
lighto After maintaining the solution under high 
vacuum for fifteen minutes, tri-O-acetyl—2-H-methylamino- 
—2—deoxy—a—B—glucopyranosyl bromide hydrobromide
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(0*8 g., 0*00175 mole) was added and the solution was
again kept under vacuum for ten minutes. Silver oxide
(1*57 g.) and dry quinoline (0.15 ml.) were added
simultaneously. The reaction was conducted as for
undeca-acetylstreptidine (3—D-glucopyranoside using
proportionately larger quantities of solvents.
The product (0*3 g., 18.5$) could not be crystallised,
2 0
m.p. 168-171° (decomp.), [a]D -11° (c 0*9 in chloroform). 
Pound: C, 46.1; H, 5.4; F, 10.6,
C3 5 H5 i 0l8 U7 .2H20 requires C, 47*0; H, 6.2; F, 11*00
4-0-Ml,5-diguanidino-2,5,6-trihydroxycyclohexyl)
2-F-methylamino-2 -de oxy-D-gluc opyranoside carbonate »
(Streptidine 2-F-methylamino-2-deoxy-3-D-glucopyranoside 
Carbonate)»
The deca-acetate obtained in the previous experiment 
was dissolved in dry methanol ( 1 0 ml.) and deacetylated 
as described for streptidine |3-D—glue opyrano side.
The chloroform—insoluble amorphous product (0*240 g. ,
??$) gave [a]p2 - 16° (c 0 * 9 5 in water), and decomposed
slowly above 180°.
Pound* ^* 36*15; H, 6.3; F, 18*2,
ci5H3i08Er7 .12- HgCOg.HgO requires C, 36.1 ; H, 6 .6 ; F, 17.9%
Streptidine 2-N-methvlamino-2-deoxv-|3-I)-gluc opyrano side
Sulphate -
The carbonate (125 mg.) obtained in the previous
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experiment was dissolved in water ( 2 ml.) and the 
solution acidified to pH 4.8 with U/ 1 0  sulphuric acid. 
The filtered solution was freeze-dried and further 
drying was affected over phosphorus pentoxide (yield 
100 mg.), [ajjj - 16.5® (e 0.8 in water).
Pound*  ^ S, 16.4,
CisH31 0sH7 *I.JT H2 S04 requires H, 16.8$
Streptidine E-H-methyl emino-2-denrv-g-i)_giu e o n v r f l „ n g ^ 0
The carbonate (30 mg.) was dissolved in water 
(0*5 ml*) and to it was added slowly picric acid 
(39 mg.) in water (3.6 ml*)* After several hours 
in the refrigerator,, the crystalline tripicrate ( 2 0 mg.) 
was collected, m.p* 269-271° (decomp., micro-block).
Poxmd: C, 33.4; H, 4.2; ff, 18.8,
C:33H4 o02 9 IT16 *2H20 requires C, 34*2; H, 3.8; H, 19,'« 070
thylamino-2-deoxy-a-L-glucopyranose Hydrochloride.
was prepared by the procedure of Kuehl, Flynn, Holly,
2 2 6
Mozingo and Folkers*
^>4, 6-Tr i-O-ac e t yl—2-H-me thyl amin o - 2-d e oxy-ct-L-gluc o—
pyranosyl Bromide Hydrobromide.
Acetyl bromide (3.3 g., 0.027 mole) was stirred with
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2 -H-methylamino-2 -deoxy-a-L-glucopyranose hydrochloride 
(1*165 g., 0.0051 mole) at room temperature for twenty 
four hours. It was purified by the procedure used for
3,4,6-tri-0-acetyl-2-lT-methylamino-2-deoxy-D-glucopyranosyl 
bromide hydrobromide using proportionate quantities of 
the solvents. The amorphous hygroscopic powder 
(1.1 g., 47<fo) gave m.p. 114-116° (decomp.), [a] ^ 2 - 148°
(c 0.9 in acetone).
Pound: IT, 3.0; Br, 32.7,
C1 3 H20 07 lTBr.HBr.H2 0 requires K, 2.9; Br, 33.2$
4--0-(3-[l,5-bis(di ac e tylguanidino) —2,5,6-triacetoxycyclohexyl] 
tri-_0-ac e tyl-2-N-me t hylamino-2-de oxy-I-gluc opyrano side . 
(Beca-acet.vlstrentidine 2-N-methvlamino-2-deox.v—B-L- 
-glucopyranoside).
Hepta-acetylstreptidine (1.40 g., 0.0019 mole) 
was dissolved in NH-dimethylformamide ( 1 0 ml.) in a 
flask protected from light. After keeping the solution 
under high vacuum for fifteen minutes with continuous 
stirring * 3,4,6-tri^0-acetyl-2—H-methylamino—2-deoxy-a— 
-I-glucopyranosyl bromide hydrobromide (0.9 g., 0.0019 mole) 
was added and the solution again maintained under high 
vacuum for ten minutes. Silver oxide (1.25 g.) and 
dry quinoline (0 . 1 2 ml.) were added simultaneously.
The reaction was conducted as for undeca-acetylstreptidine
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P-D-glucopyranoside using proportionately larger
quantities of solvents. The product (0.51 g., 30$)
could only be obtained in an amorphous condition and
2 1
had m.p. 171-173° (decomp.), [a]j> - 20° (c 8.4 in
chloroform) •
Pound: C, 46.5; H, 5.5; N, 11.1,
0 3 5 0 5 ! 01 8 H7 .2H20 requires C, 47.0; H, 6.2; N, 11.0#
4-0-6—(1,3-diguanidino-2,5,6-trihydroxycyclohexyl) 
2-0 -methylamino-2-deoxy-L-glucopyranoside Trihydrochloride.
(Streptidine 2-0-methylamino-2-deoxy-|3-L-glucopyranoside 
Trihydrochloride).
The deca-acetate (0.41 g.) obtained in the 
previous experiment was dissolved in dry methanol ( 1 0 ml.) 
and deacetylated by the procedure used for streptidine 
6 -D-glucopyranoside yielding 0.175 g. of the amorphous 
base.
The amorphous precipitate was redissolved in water
3 ml. and the solution acidified with 0 / 1 0  hydrochloric
acid to pH 4.8. After decolourisation (charcoal),
the solution was freeze-dried giving the white hygroscopic
2 2
trihydrochloride, m.p* 178-180° (decomp.), [a]D - 29.5°
(c 0 . 8 in water)•
Pound: 31.3; H, 6.2; 0, 17.5,
C16H31 O807 .SHCl.Hg 0 requires C, 31.9; H, 6.4; 0, 17.4$
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Streptidine 2—IT—methylamino—2 —deoxv—3—L—glueopyranoside 
Tripicrate.
The amorphous base (25 mg,) obtained in the previous 
experiment was dissolved in water (0 . 5 ml.) and to it 
was added cold saturated solution of picric acid ( 3 ml.) 
at 45°. The mixture when cooled in the refrigerator 
yielded the crystalline tripicrate (aqueous methanol), 
m.p. 268-270° (decomp., micro-block).
Pounds C, 33.6; H, 3.5; N, 18.9,
^5 3 H4 o 02 gITi6 *2H2 0 requires C, 34.2; H, 3.8; IT, 19.3^
2-Hydroxye thyl t e tra-O-ace tyl-p-D-gluc opyrano side was 
prepared from acetobromoglucose by the method of
324
Pischer and Pischer ; yield, 46^, m.p. 100-102°,
[a] ^ 9 — 26° (c 0 . 8 8  in chloroform). Pischer and
1 6
Pischer give m.p. 101-103°, [a]p - 26°.
2—Toluene-jq-sulphonyl oxyethyl te tra-.Q-ac e tyl-p-D- 
-glue opyrano side. (2—Tosyloxyethyl tetra—0-acetyl (3— 
glueopyranoside).
2-Hydroxyethyl tetra-O-acetyl-|3-D-glucopyranoside 
(3.03 g., 0.0078 mole) was dissolved in dry pyridine 
(3 ml.) and cooled in ice. A solution of dry toluene-jD—
3 2 5
-sulphonyl chloride (1.631 g., 0.0085 mole) in dry 
pyridine (3 ml.) was added slowly. The solution was 
kept at 0° for two and a half hours. After the reaction
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ice-cooled water (60 drops) was stirred in over a period
of fifteen minutes, followed by a further addition of
cold water (50 ml.)* The white precipitate, after
trituration, was collected and washed with cold water
(2 x 20 ml.). The precipitate, dried in a vacuum
desiccator, was dissolved in chloroform (25 ml.),
the solution was dried (CaCl2) and evaporated.
The viscous residue was dissolved in warm dry ether
( 2 0 0  ml.) and cooled slowly to 0 ° to yield white
needles of 2-toluene-£-sulphonyloxyethyl tetra-0-
-acetyl-{3-I)-glucopyranoside (2.298 g., 54.5$),
1 8
m.p. 109-110°, [cc] — 13.1° (c 2.0 in chloroform)
^max. 225 (( 5947), 262 (£ 297.5) in ethanol.
Founds C, 50.4; H, 5.6; S, 5.4,
C2 3 H3 oOl3S requires C, 50.5; H, 5.5; S, 5.9$
4—F1.3—bis(diacetylguanidino)-2 .5.6-tri-acetoxvcvclohexvl1- 
—oxye thyl te tra-O-ace tyl-P-D-gluc opyrano side. 
(Undeca-acetylstreutidine-oxyethyl-P-D-glucopyranoside).
Eepta-acetylstreptidine dihydrobromide (2.185 g., 
0.003 mole) was dissolved in lET-dimethylformamide (10 ml.) 
in a flask wrapped in a black paper. The solution was 
kept in vacuo (0 . 2 mm.) for fifteen minutes. Drierite 
(3.01 g.) and silver oxide (2.5 g.) were added and the 
mixture was stirred for thirty minutes. 2-Toluene—p—
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sulphonyloxyethyl tetra-O-acetyl-p-D-glucopyranoside 
(1*515 g., 0*0029 mole) in two portions was added 
after thirty minutes interval. The mixture was 
stirred at 95° for eight hours. After the reaction, 
the solvent was evaporated off leaving a viscous residue 
which was triturated and extracted with dry ether 
(5 x 20 ml.)* The ether extract afforded 0.25 g. 
of unreacted crystalline 2—tosyloxyethyl tetra-0-acetyl 
[3—F-glucopyranoside. The ether-insoluble residue was
extracted with absolute chloroform (5 x 10 ml.).
The reddish brown chloroform extract was kept in the 
refrigerator overnight and hydrogen sulphide then passed 
into the cold solution. The filtrate was concentrated 
in vacuo to about 1 0  ml. and poured slowly into dry 
ether (100 ml.). The tan-coloured precipitate was 
dissolved in acetone ( 1 0 0 ml.) and the solution filtered, 
decolourised with charcoal (0.3 g.) and poured slowly 
into dry ether (100 ml.) yielding 1.38 g. of amorphous 
•product, m.p. 168-171° (decomp., micro-block).
Pounds 9.5,
e2-5 4 02 j.Hg requires N, 9.0$
Further purification by chromatography on Silene EF 
2 2 2
and Celite (5:1 by weight) in various solvents did not 
improve the above constants, neither could crystallisation 
be achieved. This product was, consequently used in the
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next experiment,
4—^l«5-diguanidino-2.5,6-trihydroxycyclohexyl)-oxyethyl
6-D-glucopyranoside. (Streptidine-oxyethyl 6-D-
-fflucopyranoside),
Undeca-acetylstreptidine-oxyethyl |3-D-glucopyranoside
(1*05 g.) was dissolved in dry methanol (10 ml.) and
deacetylated as described for streptidine |3-D-glucopyranoside
to yield streptidine-oxyethyl 6-D-glucopyranoside
2 2
(0*41 g., 73$), m.p. 160-162° (decomp.), [a]^ - 18°
(c 2.7 in water).
Pounds C, 39.8; H, 6.2; N-, 16.4,
0± 6H3 2 0± 0 F6 .HgO requires C, 39.5; H, 7.0; K, 17.3$
The attempts to crystallise the product were without 
success.
Streptidine-oxyethyl P-D-glucopyranoside Dihydrochloride.
The glucoside (0.15 g.) obtained in the previous 
experiment was dissolved in dry methanol (3 ml.) and 
the solution cooled in ice mixture. It was acidified 
with 2N hydrochloric acid (1 . 6  ml.) and slowly added to 
dry ether (50 ml.). The white precipitate was washed 
with dry ether and dried in a vacuum desiccator yielding 
the white hygroscopic dihydrochloride. m.p. 190-192°
(decomp.). A sample for analysis was dried at 80° 
in vacuo for three hours.
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Founds IT, 15.6,
Ci6^32 Oio^6•8HC1 requires N, 15.5#
Streptidine-oxyethyl (3-F-gluc opyranoside Fihelianthate.
A solution of methyl orange (0.15 g.) in water 
( 8 ml.) at 70° was added to the solution of the base 
(0 . 1 2  g.) in 80 per cent aqueous methanol ( 2 ml.) 
at 40°. The solution was allowed to cool at room 
temperature when crystallisation commenced and then 
kept in the refrigerator overnight. The crystals 
were filtered off and washed with a few ml. of cold water.
It was recrystallised from hot 33 per cent aqueous 
methanol yielding 0.15 g. of the crystalline product, 
m.p. 240-243° (decomp., micro-block).
Found: C, 46.6; H, 5.9; E, 15.5; S, 6.1,
C4 4 H64 01 6 El2 S2 .2H20 requires C, 47.3; E, 6.1; E, 15.1; S, b*7f>
Attempted Condensation of 2-Bromoethyl tetra-0-acetyl- 
-{3-D-glucopyranoside and 2-Chloroethyl tetra-O.-acetyl- 
-£-D-glucopyranoside with Cyclohexanol.
3 19
2-Bromoethyl tetra-O-acetyl-p-F-glucopyranoside 
(0 . 4 7 7  g.) was added to cyclohexanol ( 2 ml.) (dried over 
Ea2 S04 and distilled). Addition of absolute chloroform 
afforded a clear solution. Quinoline (4 drops) and 
silver oxide (0 . 5 5  g.) were added simultaneously and the
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mixture was stirred for eighteen hours. The silver 
salts were removed by filtration and washed with 
absolute chloroform (25 ml.). The chloroform solution 
on evaporation yielded a clear liquid. The addition 
of light petroleum (50 ml.) (b.p. 40-60°) to this 
liquid afforded a white precipitate (0.4 g.) m.p. 115-116° 
(from ethanol) of unreacted glucoside. The filtrate 
after precipitation of glucoside was evaporated
, 2 2.5 —  J AC. q
in vacuo. The viscous liquid gave 
(Heilbron8 4 8 gives = 1.465 for cyclohexanol)
Similarly starting materials were obtained by
3 19
using 2-chloroethyl tetra-0-acetyl-P-D-glucopyranoside 
and cyclohexanol.
Strepturea B-L—Dihvdrostre-ptobiosaminide.
Dihydrostreptomycin sulphate (0.756 g.) in water
2 2 4 8 6
(5 ml.), was refluxed for one hour with 0.35E
barium hydroxide solution (25 ml.). ' The ammonia was
distilled off in a stream of nitrogen into a flask 
containing 2 0 ml. of N/1.0 hydrochloric acid and found 
to be equivalent to two moles. Excess barium hydroxide 
was precipitated by the addition of solid carbon dioxide 
and the solution centrifuged, filtered and decolourised 
(charcoal). The resulting solution was freeze-dried 
giving a white solid (0.51 g., 84.3$). Micro-crystalline 
•product was obtained from aqueous methanol and ethanol
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and dried in vacuo at 60° for three hours, decomposed
1 9
above 280° and had [a]^ - 90.1° (c 1.32 in water).
Pounds C, 40.8; H, 7.5; tf, 11.6,
C2 1 H3 9 01 4 ]^5 .2H20 requires C, 40.6; H, 7.0; IT, 11.3#
Deca-acetvlstrepturea 6-L—Dihydrostrentobiosaminide
Stretp.urea p-L-dihydrostreptobiosaminide (0.26 g.) 
was suspended in dry methanol ( 1 0 ml.) and pyridine 
(5 ml.). Acetic anhydride (5 ml.) was stirred in slowly. 
The substance dissolved in about half an hour and the 
solvent removed in vacuo below 50°. The residue was 
thoroughly washed with dry ether. The white 
hygroscopic solid was again acetylated in pyridine (5 ml.) 
with acetic anhydride (5 ml.), the latter being stirred 
in slowly. The substance dissolved in about 1.5 hour 
and the solution was kept at room temperature for 40 hours 
with occasional shaking. The reaction was completed 
by heating the solution at 45° for 4 hours with stirring. 
The solvents were removed in vacuo below 45° and the 
residue triturated and washed with petroleum ether 
(b.p. 40-60°), gave a white solid which was soluble in 
methanol and partially soluble in chloroform, ethanol 
and benzene. The product crystallised from methanol— 
-ethanol gave dec a-ac e t vis tr ex> tur e a 6 -L-dihy dr o s tr en t obi os— 
aminide (0.097 g.), m.p. 256—258°, [oc]p — 73.3°
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(a 0.96 in methanol),
Founds G, 47.4* H, 6.0; N, 7.3,
C4 iH5 9 0 2 4 N5 .2H20 requires C, 47.3; H, 6.1; 1ST, 6.7$
Streptamine 6-L-dihydrostreptobiosaminide Trihvdrochloride 
Dihydrostreptomycin sulphate (5.125 g.) was 
heated under reflux, over a water-bath with 0.35N
2 2 4 2 8 6
barium hydroxide (350 ml.) for twenty four hours. 9 
The cooled solution was neutralized with solid carbon 
dioxide, filtered and evaporated in vacuo below 50° 
to yield a pale yellow solid (2.85 g.) which gave a 
positive test for primary amino group with ninhydrin
3 2 9
solution and negative tests for guanidino and urea 
groups with sodium nitroprussidepotassium ferricyanide
3 3 0
solution . The base was purified by adsorption on 
charcoal ( 2 g.), impurities being removed by washing 
with water (3 x 10 ml.) and methanol (3 x 10 ml.).
The charcoal was suspended in methanol (15 ml.) at 
about 1 0 ° and treated with N methanolic hydrochloric 
acid ( 3 ml.), stirred vigorously for ten minutes, 
filtered and the charcoal washed with methanol ( 2 x 1 0  ml.). 
The combined filtrates were concentrated in vacuo to 10 ml. 
and added to dry ether. The white precipitate (0.25 g.) 
was washed twice with dry ether and dried in a desiccator
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to yield the trihydrochloride. m.p* 194-196° (decomp.),, 
[a]jj — 8 8 .6 ° (c 0.94 in water). A sample for 
analysis was dried at 80° for three hours.
Pounds C, 36.3; HT, 6.7; N, 7.2,
9S3 7 0x2 ^3 .3SC1.H20 requires C, 36.4; H, 6.75? IF, 6.7$
Eeca-acetylstrentamine g—L-dihydrostreotobiosaminide 
The base (0.3 g.) obtained in the previous 
experiment was acetylated as for deca-acetylstrepturea 
(3-L-dihydrostreptobiosaminide. The product crystallised 
from methanol-ethanol gave deca-acetylstreptamine p-L- 
-dihydrostreptobiosaminide (0.192 g.), m.p. 260—262°,
2 0 2 3 3
[a]^ — 83° (c 1.0 in methanol). Wolfrom and Polglase
give m.p. 261.5-262.5° and [cx]p3 - 84°.
4-0-(1,3-diureido-2,5,6 —trihydroxycyclohexyl) 2-amino—2- 
-deoxy-p-D-glucopyranoside sulphate. (Strepturea
2 -amino-2-deoxy—p-E-glucopyranoside sulphate) .
A solution of streptidine 2-amino-2-deoxy-p-D- 
-glucopyranoside sulphate (0.42 g.) in water (3 ml.) 
and 0.35E barium hydroxide (15 ml.) were refluxed over 
a water-bath for one hour. Excess barium hydroxide 
was precipitated by the addition of solid carbon dioxide. 
The solution was centrifuged, filtered and decolourised 
(charcoal). The resulting solution was freeze-dried
14?
giving a. white powder which showed the presence of 
barium salts, though in very small amounts. The substance 
was, therefore, redissolved in water ( 2 ml.), cooled and 
acidified with N sulphuric acid to pH 4.9. The precipitate 
of barium sulphate was removed by centrifugation.
The filtered solution was diluted with methanol (25 ml.) 
and precipitation of the sulphate was facilitated by 
the addition of dry ether ( 1 0 0  ml.) and by keeping in 
the refrigerator overnight. The ether solution was 
decanted and the residue was washed with dry ether 
and dried in vacuo over phosphorus pentoxide to yield 
the product (0.25 g., 71$), m.p. decomposed slowly 
above 2 2 0 °.
Pound: C, 32.6* H, 5.9* 13.8,
^1 4 ^ 2 7  ^ io^5 H2 S04 .2H2 0 requires C, 33.0* H, 6.3* H, 13.7$
4-0-(l,3-diamino-2,5,6 -trihydroxycyclohexyl) 2-amino— 2— 
-deoxy-fi-D-glucopyranoside. (Streptamine 2-amino-~2-deoxy-- 
-ft-D-glucopyranoside).
Streptamine 2-amino-2-deoxy—p-D-glucopyranoside 
(0.452 g.) was heated under reflux over a water bath 
with 0.35N barium hydroxide (50 ml.) for twenty four 
hours. Excess of barium hydroxide was precipitated 
with solid carbon dioxide. The precipitate was 
centrifuged and the solution filtered. The filtrate was
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freeze—dried. The amorphous substance showed the 
presence of primary amino groups with ninhydrin
329
solution but gave negative tests for guanidine and 
urea groups with sodium nitroprusside, potassium
„ 330
ferncyanide solution. The freeze-dried substance
was redissolved in water (5 ml.) and the solution 
cooled. Traces of barium salts were removed by 
acidification with H/ 1 0  sulphuric acid to pH 4 *
Barium sulphate was centrifuged and the solution was 
decolourised (charcoal). The colourless solution was 
passed through a small column of De-Acidite PP (5 g.) 
and the column was washed with water ( 1 0 ml.).
The combined eluates were freeze-dried giving a white 
amorphous base (0,181 g,t 67$), m.p, 160-162° (decomp.).
A sample for analysis was dried at 80° in vacuo for 
three hours
Pound: C, 42.2; H, 7.1; H, 12.5,
C^HggOgETs requires C, 42.5; H, 7.4; H, 12.4$
Attempted Anomerization of Bodeca-acetvldihvdrostre-ptomvcin
3 3 5
(a) A. freshly distilled solution of boron trifluoride- 
-ether complex in absolute chloroform ( 1 0 ml.) was 
added to a solution of dodeca-acetyldihydrostreptomycin 
(0.102 g.) in absolute chloroform (10 ml.). There was
only a slight decrease in optical rotation over a period
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of eighteen hours* The chloroform solution was washed 
with cold water, cold saturated solution of sodium 
bicarbonate and dried (Ra2 S04). Removal of the 
solvent and purification of the residue gave only- 
starting material m.p. 150-153° (decomp.), [a]*° - 60°
(in chloroform).
3 3 6
(b) A solution of stannic chloride (0.0279 g.) 
in absolute chloroform ( 1 0 ml.) was added to 
dodeca-acetyldihydrostreptomycinT (0 . 2  g. ). The precipitate 
which separated after two days was removed by 
centrifuging and the chloroform washed with ice-cold
water and dried (Ra2 S04). Removal of the solvent and 
precipitation of the residue in acetone with petroleum 
ether (b.p. 80—100°) gave a product which did not melt 
below 300° and was not, therefore, investigated further.
3 3 6
(c) A 4 per cent solution of titanium tetrachloride
in chloroform ( 2 ml.) was added to dodeca-aeetyldihydro— 
streptomycin (0 . 2 0 1  g.) in absolute chloroform ( 2 ml.).
The mixture was refluxed for six hours, cooled, poured 
on to ice and extracted with chloroform. Removal of 
the solvent gave only impure starting material.
(d) Dodeca-acetyldihydrostreptomycin (0.1 g.) in 
acetic anhydride (2 ml.) was treated with a mixture of
150
concentrated sulphuric acid (0.25 ml.) in acetic
3 3V
anhydride (ca. 2.3 ml.) and the volume adjusted 
to 5 ml. with acetic anhydride. The optical rotation 
reached a constant value after an hour and a half.
The reaction mixture was poured on to the crushed ice 
(150 g.) containing sodium acetate (2.5 g.) and extracted 
with chloroform as before. Removal of the solvent 
and extraction of the residue with dry ether gave
34 4
tetra-acetylbisdeoxystreptobiosaminide (24 mg.)
Bup. 159-161°, [a]|j0 - 85.8° (c 0.8 in chloroform)
and a very small ether-insoluble portion which was
-20
probably hepta-acetylstreptidine, LaJp — 3° (methanol).
3 3 8
(e) Drierite (1 . 0 1  g.) and sodium hydroxide (0 . 1 1 1  g.) 
was shaken in a mixture of dry dioxane (5 ml.) and dry 
ether (5 ml.). Dodeca-acetyldihydrostreptomycin (0.1 g.) 
was added and the whole shaken for a further period of 
eight hours. The dioxane-ether insoluble portion was 
taken up in dry methanol ( 1 0 ml.) containing acetic 
anhydride (2 ml.) and filtered. Evaporation of the 
filtrate to dryness gave a crude residue containing 
sodium acetate and some partially deacetylated material 
from which 60 mg. of starting material m.p. 148—150°,
[a]^° - 62° (in chloroform) was recovered on reacetylation 
with acetic anhydride in pyridine.
BJLC I K S  I 0 I?_0_g_I 0 A I 
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Tuberculostatic Activity of Streptomycin Derivatives.
The in vitro evaluation of the antitubercular 
activity of some of the compounds synthesised in this 
work was carried out by G-laxo laboratories Ltd. to whom 
the author wishes to express his thanks.
Each compound was dissolved in water (1000/x.g. ml.), 
the solution diluted in Dubos* liquid medium and the 
dilution inoculated with Mycobacterium tuberculosis 
(human strain 666). The results were recorded after 
fourteen days incubation at 37° and again after twenty 
eight days and are shown in tables 2 and 3. Eor the 
purpose of comparison, the test was also carried out 
on streptomycin.
Table 2
Inhibition of Mycobacterium tuberculosis in
C o m p o u n d
Streptomycin (XXIa)
K-acetylstreptomycin(XKXTIIIc)
N-acetyldihydrostreptomycin (XXXVIIIb)
N-acetyltrityldihydrostreptomycin (XXXVTIIa)
Undeca-acetylstreptomycin (XXXTIIa)
Dodeca-acetyldihydrostreptomycin (XXXVIIe)
Streptidine p-D-glucopyranoside (1VIII)
Streptidine 2-amino-2-deoxy-P-D-glucopyrano­
side sulphate (LXl)
Streptidine 2-U-methylamino-2-deoxy-P-3)— 
-glueopyranoside sulphate (LXXIX)
Streptidine 2—U-methylamino-2-deoxy—p-L— 
-glucopyranosidetrihydrochloride (LXXX)
Streptidine-oxyethyl p—D-glucopyranoside (XC)
Strepturea dihydrostreptobiosaminide (XXVII)
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Dubos 1 Liquid Medium after incubation at 37* for 14 days.
Concentration jjlg. / ml.
100 50 25 12.5 6.25 3.12 1.56 0.78 .4 • 2 .1 .05
- - - - - - ++ ++
- - - + + ++ ++ ++
- -  - - + ++ ++ ++ ++
- - + + ++ ++ ++ ++ ++ ++ ++ ++
++ ++ ++ ++ ++ ++ ++ ++ *t*+ ++ ++ ++
++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
- + ++ ++ ++ ++ ++ ++ ++ ++ ++
++ ++ ++ ++ ++ ++ +■+ ++ ++ ++ ++ ++
+4* ++ ++ ++ ++ ++ ++ <++ ++ ++ ++
++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
- - +_ + ++ ++ ++ ++ ++ ++ ++
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Table 2 (contd*)
Compound
Streptamine dihydrostreptobiosaminide- 
trihydrochloride (XXVIII)
Strepturea 2-amino-2-deoxy p-D-glucopyranoside 
sulphate (XCII)
Streptamine 2-amino-2-deoxy p-D-glucopyranoside 
(XCIII)
Table 3
Inhibition of Mycobacterium tuberculosis in
Compound
Streptomycin (XXIa)
F-acetylstreptomycin (XXXVIIIc)
F-ac etyldihydrostrep tomycin (XXXVIIIb) 
F-acetyltrityldihydrostreptomycin (XXXVIIIa)
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Concentration a g./ml.
100 50 25 12.5 6.25 3.12 1.56 0.78 .4 • 2 .1 .05
++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
++ ++ ++ ++ ++ ++ ++ ++ ++ +■+ ++ ++
++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
Table 3
r'le.dium
Dubos 1 Liquid/after incubation at 37* for 28 days.
Concentration g./ml.
100 50 25 12.5 6.25 3.12 1.56 0.78 .4 .2 .1 .05
— - - - - - - - +_ + ++ ++
- - - + ++ ++ ++ ++ ++
- - +_ + + ++ ++ ++ ++ ++
- + ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
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Concilia ion
The results recorded in table 2 and table 3 
show that whereas IT-ace tyl streptomycin and U-acetyldihydro- 
streptomycin are somewhat less active than streptomycin 
itself, activity is significantly less in N-acetyltrityl— 
dihydrostreptomycin. This, therefore, lends further 
support for the view that microbiological oxidation of 
dihydrostreptomycin to streptomycin is a pre-requisite 
for the activity of the former and the streptose-aldehyde 
group is essential for the activity of the latter*
Substitution of the streptobiosamine fragment in 
the streptomycin molecule by such carbohydrates as 
D-glucose, D-glucosamine, N-methyl-a—D-glucosamine, 
IT-methyl-a-L-glucosamine and 2-hydroxy ethyl p-D-glucoside, 
leads to the abolition of tuberculostatic activity.
This father stresses the importance of the streptose 
unit for the activity of the antibiotic. Further, the 
conversion of guanidino groups to either ureido or 
amino groups abolishes the activity of dihydrostreptomycin. 
Is was anticipated, none of the acetylated intermediates 
showed significant activity.
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